| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:10996 | 6480464 | alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased expression of NOS2 protein] | CTD | PMID:19135433 |
| (+)-alpha-viniferin | multiple interactions | ISO | RGD:10996 | 6480464 | alpha-viniferin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:14531020 |
| (+)-alpha-viniferin | multiple interactions | ISO | RGD:10996 | 6480464 | alpha-viniferin inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20424383 |
| (+)-catechin | multiple interactions | ISO | RGD:10996 | 6480464 | Catechin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 |
| (+)-pilocarpine | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [Pilocarpine results in increased expression of NOS2 protein] | CTD | PMID:18672383 |
| (+)-pilocarpine | multiple interactions | EXP | | 6480464 | [Pilocarpine co-treated with Lithium] results in increased expression of NOS2 protein; more ... | CTD | PMID:20149694 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of NOS2 protein | CTD | PMID:18672383 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:10996 | 6480464 | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12794164 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:10996 | 6480464 | epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; more ... | CTD | PMID:20438794 |
| (E)-roxithromycin | multiple interactions | ISO | RGD:730951 | 6480464 | Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | CTD | PMID:17524151 |
| (E)-roxithromycin | multiple interactions | EXP | | 6480464 | Roxithromycin inhibits the reaction [Diethylnitrosamine results in increased activity of NOS2 protein] | CTD | PMID:16061884 |
| (R)-adrenaline | increases expression | EXP | | 6480464 | Epinephrine results in increased expression of NOS2 mRNA | CTD | PMID:16925470 |
| (R)-adrenaline | multiple interactions | ISO | RGD:10996 | 6480464 | Atenolol inhibits the reaction [Epinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:19439816 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Thioctic Acid inhibits the reaction [Cisplatin results in increased expression of NOS2] | CTD | PMID:21763304 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]]; more ... | CTD | PMID:15705589 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of NOS2 mRNA]] | CTD | PMID:17729120 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:10996 | 6480464 | [GW 274150 results in decreased activity of NOS2 protein] which results in increased susceptibility to Norepinephrine | CTD | PMID:16424707 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:10996 | 6480464 | Atenolol inhibits the reaction [Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:19439816 |
| (R)-noradrenaline | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Norepinephrine | CTD | PMID:16424707 |
| (S)-colchicine | multiple interactions | EXP | | 6480464 | Colchicine inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA] | CTD | PMID:23146695 |
| (S)-naringenin | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18274639 |
| (S)-naringenin | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10188978 |
| (S)-naringenin | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:10188978 PMID:18274639 |
| (S)-naringenin | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18274639 PMID:12512693 |
| (S)-naringenin | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 PMID:18274639 |
| (S)-nicotine | multiple interactions | ISO | RGD:730951 | 6480464 | Nicotine promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide] | CTD | PMID:16927020 |
| (S)-nicotine | increases expression | ISO | RGD:10996 | 6480464 | Nicotine results in increased expression of NOS2 mRNA | CTD | PMID:21237301 PMID:16254210 |
| (S)-nicotine | increases expression | ISO | RGD:10996 | 6480464 | Nicotine results in increased expression of NOS2 mRNA | CTD | PMID:16254210 PMID:21237301 |
| (S)-nicotine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21237301 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of NOS2 mRNA; more ... | CTD | PMID:19673871 |
| (S)-nicotine | increases expression | ISO | RGD:10996 | 6480464 | Nicotine results in increased expression of NOS2 mRNA | CTD | PMID:16254210 |
| (S)-nicotine | multiple interactions | ISO | RGD:10996 | 6480464 | [Nicotine results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:17135361 |
| (S)-nicotine | decreases expression | ISO | RGD:10996 | 6480464 | Nicotine results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:17135361 |
| (S)-nicotine | increases expression | ISO | RGD:730951 | 6480464 | Nicotine results in increased expression of NOS2 protein | CTD | PMID:16927020 |
| (S)-nicotine | increases expression | ISO | RGD:730951 | 6480464 | Nicotine results in increased expression of NOS2 mRNA | CTD | PMID:18247414 |
| 1,2-dimethylhydrazine | increases expression | ISO | RGD:10996 | 6480464 | 1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA | CTD | PMID:22982865 |
| 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA | CTD | PMID:18155637 |
| 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Vanadium inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] | CTD | PMID:18155637 |
| 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] | CTD | PMID:22982865 |
| 1,3,5-trinitrobenzene | multiple interactions | ISO | RGD:10996 | 6480464 | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of NOS2 mRNA] | CTD | PMID:15890784 |
| 1,3,5-trinitrobenzene | increases expression | ISO | RGD:10996 | 6480464 | sym-trinitrobenzene results in increased expression of NOS2 mRNA | CTD | PMID:15890784 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:730951 | 6480464 | Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]] | CTD | PMID:9755104 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:10996 | 6480464 | Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:15907790 |
| 1,4-dithiothreitol | multiple interactions | EXP | | 6480464 | Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | CTD | PMID:7532384 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:730951 | 6480464 | Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]; more ... | CTD | PMID:9706149 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of NOS2 protein | CTD | PMID:17373747 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Dinitrochlorobenzene results in decreased expression of NOS2 protein] | CTD | PMID:17373747 |
| 1-hydroxy-2-naphthoic acid | multiple interactions | ISO | RGD:10996 | 6480464 | 1-hydroxy-2-naphthoic acid analog inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21667204 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NOS2 protein | CTD | PMID:22940226 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:10996 | 6480464 | VIP protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased activity of NOS2 protein] | CTD | PMID:12626429 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases activity | ISO | RGD:10996 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased activity of NOS2 protein | CTD | PMID:12626429 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NOS2 protein]; more ... | CTD | PMID:22940226 |
| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of NOS2 protein | CTD | PMID:18590720 PMID:18364083 |
| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of NOS2 protein | CTD | PMID:18364083 PMID:18590720 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| 1-naphthyl isothiocyanate | multiple interactions | EXP | | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein]; more ... | CTD | PMID:18590720 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:730951 | 6480464 | [Ethinyl Estradiol co-treated with drospirenone] results in decreased expression of NOS2 mRNA | CTD | PMID:19631796 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10996 | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15256495 PMID:11063824 |
| 17beta-estradiol | increases expression | ISO | RGD:730951 | 6480464 | Estradiol results in increased expression of NOS2 mRNA | CTD | PMID:11583108 |
| 17beta-estradiol | multiple interactions | ISO | RGD:730951 | 6480464 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [[Estradiol co-treated with ESR2] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11583108 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NOS2 protein | CTD | PMID:11583108 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [Estradiol results in increased expression of NOS2 protein]; more ... | CTD | PMID:11583108 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of NOS2 protein | CTD | PMID:16006544 PMID:17053178 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10996 | 6480464 | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:15256495 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10996 | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11063824 PMID:15256495 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of NOS2 protein | CTD | PMID:17053178 PMID:16006544 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of NOS2 mRNA | CTD | PMID:17053178 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol inhibits the reaction [RELA protein binds to NOS2 promoter] | CTD | PMID:17053178 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of NOS2 mRNA | CTD | PMID:12810170 |
| 17beta-estradiol | increases expression | ISO | RGD:10996 | 6480464 | Estradiol results in increased expression of NOS2 mRNA | CTD | PMID:17873880 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10996 | 6480464 | Estradiol inhibits the reaction [manganese chloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21512103 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10996 | 6480464 | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17873880 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | EXP | | 6480464 | [pimagedine inhibits the reaction [testosterone enanthate results in increased expression of NOS2 mRNA]] which results in increased secretion of Dihydrotestosterone | CTD | PMID:20463352 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:730951 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:730951 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA | CTD | PMID:11007951 |
| 2,4,6-trinitrobenzenesulfonic acid | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Trinitrobenzenesulfonic Acid | CTD | PMID:17449036 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10996 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein | CTD | PMID:20923188 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:10996 | 6480464 | soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] | CTD | PMID:20923188 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein | CTD | PMID:11698051 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | kappa-casein glycomacropeptide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein]; more ... | CTD | PMID:15867298 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10996 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | CTD | PMID:11717450 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10996 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | CTD | PMID:11717450 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:19285099 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10996 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | CTD | PMID:17982090 PMID:11717450 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:10996 | 6480464 | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:11717450 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein | CTD | PMID:11698051 PMID:17276891 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:22039321 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | CTD | PMID:21893697 PMID:22039321 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:21893697 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein | CTD | PMID:17276891 PMID:11698051 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] | CTD | PMID:11698051 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:10996 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA | CTD | PMID:17982090 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:730951 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of NOS2 mRNA | CTD | PMID:21034357 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:22107987 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of NOS2 mRNA] | CTD | PMID:19796704 |
| 2-amino-2-deoxy-D-galactopyranose | increases expression | EXP | | 6480464 | Galactosamine results in increased expression of NOS2 protein | CTD | PMID:15565661 PMID:22310181 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [Galactosamine results in increased expression of NOS2 protein] | CTD | PMID:22310181 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:21401295 |
| 2-amino-2-deoxy-D-galactopyranose | increases expression | EXP | | 6480464 | Galactosamine results in increased expression of NOS2 mRNA; more ... | CTD | PMID:15565661 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | Galactosamine promotes the reaction [Alprostadil results in increased expression of NOS2 protein] | CTD | PMID:15189274 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | Alprostadil inhibits the reaction [Galactosamine results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15565661 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:730951 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein | CTD | PMID:17605605 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:17440993 PMID:18205790 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:19098112 PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of NOS2 mRNA | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of NOS2 mRNA | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:20737476 PMID:19098112 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; more ... | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18205790 PMID:17440993 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:730951 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA] | CTD | PMID:18077487 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:730951 | 6480464 | Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein]] | CTD | PMID:21145922 |
| 2-naphthylamine | increases expression | ISO | RGD:730951 | 6480464 | 2-Naphthylamine results in increased expression of NOS2 mRNA | CTD | PMID:18247414 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]] | CTD | PMID:15705589 |
| 25-hydroxycholesterol | increases expression | ISO | RGD:730951 | 6480464 | 25-hydroxycholesterol results in increased expression of NOS2 mRNA | CTD | PMID:12085989 |
| 25-hydroxycholesterol | increases expression | ISO | RGD:10996 | 6480464 | 25-hydroxycholesterol results in increased expression of NOS2 mRNA | CTD | PMID:12085989 |
| 26-hydroxycholesterol | multiple interactions | ISO | RGD:10996 | 6480464 | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17873880 |
| 26-hydroxycholesterol | decreases expression | ISO | RGD:10996 | 6480464 | 27-hydroxycholesterol results in decreased expression of NOS2 mRNA | CTD | PMID:17873880 |
| 3',5'-cyclic GMP | multiple interactions | EXP | | 6480464 | [testosterone enanthate results in increased expression of NOS2 mRNA] which results in increased abundance of Cyclic GMP | CTD | PMID:20463352 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of NOS2 mRNA | CTD | PMID:15039144 |
| 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | RGD:730951 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of NOS2 mRNA | CTD | PMID:21703328 |
| 3,4-dihydroxybenzoic acid | multiple interactions | ISO | RGD:10996 | 6480464 | protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20026373 |
| 3-methylcatechol | multiple interactions | ISO | RGD:10996 | 6480464 | 3-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18499097 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | multiple interactions | ISO | RGD:10996 | 6480464 | tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of NOS2 mRNA] | CTD | PMID:22200888 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:10996 | 6480464 | Oxazolone results in increased expression of NOS2 mRNA | CTD | PMID:22200888 |
| 4-coumaric acid | multiple interactions | ISO | RGD:10996 | 6480464 | 4-coumaric acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; more ... | CTD | PMID:22366099 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:10996 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NOS2 protein | CTD | PMID:20940037 |
| 4-methylcatechol | multiple interactions | ISO | RGD:10996 | 6480464 | 4-methylcatechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18499097 |
| 4-nitroquinoline N-oxide | increases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein | CTD | PMID:12566915 |
| 4-nitroquinoline N-oxide | multiple interactions | EXP | | 6480464 | ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of NOS2 protein] | CTD | PMID:12566915 |
| 5-fluorouracil | multiple interactions | ISO | RGD:10996 | 6480464 | Fluorouracil results in increased expression of and results in increased activity of NOS2 protein | CTD | PMID:18069768 |
| 5-fluorouracil | multiple interactions | ISO | RGD:10996 | 6480464 | Fluorouracil inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:16724238 |
| 5-fluorouracil | increases expression | ISO | RGD:730951 | 6480464 | Fluorouracil results in increased expression of NOS2 protein | CTD | PMID:12150722 |
| 6-oxo-prostaglandin F1alpha | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | CTD | PMID:16325209 |
| 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA | CTD | PMID:20599847 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10996 | 6480464 | Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein] | CTD | PMID:20043298 |
| 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | [Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA] | CTD | PMID:20599847 |
| 7-ketocholesterol | increases expression | ISO | RGD:730951 | 6480464 | 7-ketocholesterol results in increased expression of NOS2 mRNA | CTD | PMID:12085989 |
| 7-ketocholesterol | increases expression | ISO | RGD:10996 | 6480464 | 7-ketocholesterol results in increased expression of NOS2 mRNA | CTD | PMID:12085989 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA] | CTD | PMID:15994020 |
| acetaldehyde | multiple interactions | ISO | RGD:730951 | 6480464 | [Acetaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:18845238 |
| acetaldehyde | increases expression | ISO | RGD:730951 | 6480464 | Acetaldehyde results in increased expression of NOS2 protein | CTD | PMID:18845238 |
| acetic acid | increases expression | EXP | | 6480464 | Acetic Acid results in increased expression of NOS2 | CTD | PMID:10898763 |
| acetic acid | multiple interactions | EXP | | 6480464 | sangre de grado inhibits the reaction [Acetic Acid results in increased expression of NOS2] | CTD | PMID:10898763 |
| acetylcholine | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine] | CTD | PMID:11498454 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:730951 | 6480464 | Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of NOS2 protein] | CTD | PMID:17218764 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21893697 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:10996 | 6480464 | [Aspirin results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:10860828 |
| acetylsalicylic acid | decreases expression | ISO | RGD:10996 | 6480464 | Aspirin results in decreased expression of NOS2 protein | CTD | PMID:10860828 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of NOS2 protein | CTD | PMID:16310244 |
| acetylsalicylic acid | increases expression | ISO | RGD:730951 | 6480464 | Aspirin results in increased expression of NOS2 protein | CTD | PMID:17218764 |
| acrolein | decreases expression | ISO | RGD:10996 | 6480464 | Acrolein results in decreased expression of NOS2 protein | CTD | PMID:20940037 |
| acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of NOS2 protein | CTD | PMID:22961095 |
| acrolein | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Acrolein results in increased expression of NOS2 protein] | CTD | PMID:22961095 |
| acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NOS2 protein | CTD | PMID:15977197 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | CTD | PMID:11286988 |
| ADP | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Adenosine Diphosphate] | CTD | PMID:11498454 |
| alachlor | multiple interactions | ISO | RGD:10996 | 6480464 | alachlor inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15907790 |
| albuterol | multiple interactions | EXP | | 6480464 | Albuterol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20519841 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:730951 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein | CTD | PMID:17605605 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:17440993 PMID:18205790 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:19098112 PMID:20737476 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of NOS2 mRNA | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of NOS2 mRNA | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:20737476 PMID:19098112 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; more ... | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18205790 PMID:17440993 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:730951 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA] | CTD | PMID:18077487 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A deficiency results in increased expression of NOS2 | CTD | PMID:16036340 |
| allyl alcohol | increases expression | EXP | | 6480464 | allyl alcohol results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| aluminium atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Iron] results in increased expression of NOS2 protein | CTD | PMID:16728372 |
| aluminium trichloride | multiple interactions | EXP | | 6480464 | [aluminum chloride co-treated with ferric chloride] results in increased expression of NOS2 protein | CTD | PMID:16728372 |
| aluminium(0) | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Iron] results in increased expression of NOS2 protein | CTD | PMID:16728372 |
| amentoflavone | decreases expression | ISO | RGD:730951 | 6480464 | amentoflavone results in decreased expression of NOS2 protein | CTD | PMID:12144868 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen]; more ... | CTD | PMID:14550746 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Acrolein results in increased expression of NOS2 protein] | CTD | PMID:22961095 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | pimagedine inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | CTD | PMID:21397503 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | pimagedine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA] | CTD | PMID:20455021 |
| aminoguanidine | decreases expression | ISO | RGD:730951 | 6480464 | pimagedine results in decreased expression of NOS2 protein | CTD | PMID:19266598 |
| aminoguanidine | decreases activity | EXP | | 6480464 | pimagedine results in decreased activity of NOS2 protein | CTD | PMID:14729435 PMID:9306416 |
| aminoguanidine | decreases expression | EXP | | 6480464 | pimagedine results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:12473873 |
| aminoguanidine | decreases activity | EXP | | 6480464 | pimagedine results in decreased activity of NOS2 protein | CTD | PMID:9306416 PMID:14729435 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [testosterone enanthate results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20463352 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein]; more ... | CTD | PMID:19481068 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] | CTD | PMID:18594475 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | CTD | PMID:11574821 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein]; more ... | CTD | PMID:17637181 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Cyclophosphamide results in increased activity of NOS2 protein] | CTD | PMID:15821589 |
| aminoguanidine | affects expression | EXP | | 6480464 | pimagedine affects the expression of NOS2 mRNA | CTD | PMID:17936468 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | [pimagedine results in decreased activity of NOS2 protein] which results in increased expression of CXCR2 protein | CTD | PMID:17138957 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | [pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA | CTD | PMID:17135264 |
| aminoguanidine | decreases activity | ISO | RGD:10996 | 6480464 | pimagedine results in decreased activity of NOS2 protein | CTD | PMID:12054156 |
| aminoguanidine | multiple interactions | ISO | RGD:10996 | 6480464 | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | CTD | PMID:12892526 |
| ammonia | multiple interactions | ISO | RGD:730951 | 6480464 | IL1B protein promotes the reaction [Ammonia results in increased expression of NOS2 mRNA] | CTD | PMID:20217200 |
| ammonia | increases expression | ISO | RGD:730951 | 6480464 | Ammonia results in increased expression of NOS2 mRNA | CTD | PMID:20217200 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NOS2 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of NOS2 protein | CTD | PMID:11923223 PMID:16483693 |
| ammonium chloride | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ammonium Chloride results in increased expression of NOS2 protein]; more ... | CTD | PMID:11923223 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of NOS2 protein | CTD | PMID:16483693 PMID:11923223 |
| amobarbital | multiple interactions | EXP | | 6480464 | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Amobarbital] | CTD | PMID:7532384 |
| amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NOS2 mRNA | CTD | PMID:18524487 |
| amphetamine | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18524487 |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 more ... |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:16944022 PMID:18306037 |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 more ... |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 more ... |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:21893697 |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:18306037 |
| anandamide | multiple interactions | ISO | RGD:10996 | 6480464 | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11891798 |
| anandamide | multiple interactions | ISO | RGD:10996 | 6480464 | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15748152 PMID:11891798 |
| anandamide | multiple interactions | ISO | RGD:10996 | 6480464 | anandamide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11891798 PMID:15748152 |
| aniline | increases expression | EXP | | 6480464 | aniline results in increased expression of NOS2 protein; more ... | CTD | PMID:21708182 |
| apigenin | multiple interactions | ISO | RGD:10996 | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11343698 |
| apigenin | multiple interactions | ISO | RGD:10996 | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934226 PMID:12512693 |
| apigenin | multiple interactions | EXP | | 6480464 | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18090225 |
| apigenin | multiple interactions | ISO | RGD:10996 | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 PMID:16934226 |
| apocynin | multiple interactions | ISO | RGD:10996 | 6480464 | acetovanillone inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of NOS2 protein]; more ... | CTD | PMID:15220209 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Formaldehyde results in increased expression of NOS2 mRNA] | CTD | PMID:21983654 |
| aristolochic acid | multiple interactions | ISO | RGD:10996 | 6480464 | aristolochic acid I inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21291967 |
| arsenic atom | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Arsenic results in decreased expression of NOS2 mRNA] | CTD | PMID:22120977 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of NOS2 mRNA | CTD | PMID:22120977 |
| arsenite(3-) | increases expression | ISO | RGD:730951 | 6480464 | arsenite results in increased expression of NOS2 mRNA | CTD | PMID:18296743 |
| arsenite(3-) | multiple interactions | ISO | RGD:730951 | 6480464 | Dietary Fats promotes the reaction [arsenite results in increased expression of NOS2 mRNA] | CTD | PMID:18296743 |
| atenolol | multiple interactions | ISO | RGD:10996 | 6480464 | Atenolol inhibits the reaction [carvedilol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; more ... | CTD | PMID:19439816 |
| ATP | multiple interactions | EXP | | 6480464 | Adenosine Triphosphate promotes the reaction [RELA protein binds to NOS2 protein]; more ... | CTD | PMID:21464294 |
| ATP | increases expression | EXP | | 6480464 | Adenosine Triphosphate results in increased expression of NOS2 protein | CTD | PMID:21464294 |
| ATP | multiple interactions | ISO | RGD:730951 | 6480464 | NOS2 protein affects the reaction [Adenosine Triphosphate results in increased metabolism of RELA protein] | CTD | PMID:21464294 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 PMID:16944022 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:16944022 |
| azathioprine | decreases expression | ISO | RGD:10996 | 6480464 | Azathioprine results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:16473374 |
| baicalein | multiple interactions | ISO | RGD:10996 | 6480464 | baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:14563492 |
| baicalein | multiple interactions | ISO | RGD:10996 | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] | CTD | PMID:22369883 |
| baicalein | decreases expression | ISO | RGD:10996 | 6480464 | baicalein results in decreased expression of NOS2 protein | CTD | PMID:20850421 |
| baicalin | multiple interactions | ISO | RGD:10996 | 6480464 | baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18187930 |
| baicalin | decreases expression | EXP | | 6480464 | baicalin results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:22019745 |
| benazepril | decreases expression | EXP | | 6480464 | benazepril results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:16191423 |
| benzene | multiple interactions | ISO | RGD:10996 | 6480464 | [Benzene promotes the reaction [[CSF1 protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:8193360 |
| benzo[a]pyrene | increases expression | ISO | RGD:730951 | 6480464 | Benzo(a)pyrene results in increased expression of NOS2 mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10996 | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] | CTD | PMID:22369883 |
| benzo[a]pyrene | increases expression | ISO | RGD:730951 | 6480464 | Benzo(a)pyrene results in increased expression of NOS2 mRNA | CTD | PMID:18247414 PMID:22316170 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21745554 |
| benzo[a]pyrene | increases expression | ISO | RGD:10996 | 6480464 | Benzo(a)pyrene results in increased expression of NOS2 protein | CTD | PMID:22369883 |
| benzyl isothiocyanate | multiple interactions | ISO | RGD:10996 | 6480464 | benzyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | CTD | PMID:18838692 |
| berberine | multiple interactions | ISO | RGD:10996 | 6480464 | Berberine inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | CTD | PMID:21095217 |
| beta-carotene | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | CTD | PMID:18779489 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:730951 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein | CTD | PMID:17605605 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:17440993 PMID:18205790 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:19098112 PMID:20737476 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of NOS2 mRNA | CTD | PMID:20737476 |
| beta-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of NOS2 mRNA | CTD | PMID:17109745 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:20737476 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17109745 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:20737476 PMID:19098112 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; more ... | CTD | PMID:20737476 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:10996 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18205790 PMID:17440993 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:730951 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of NOS2 mRNA] | CTD | PMID:18077487 |
| bilirubin | multiple interactions | EXP | | 6480464 | Bilirubin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18206168 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:730951 | 6480464 | Mustard Gas results in decreased expression of NOS2 protein; more ... | CTD | PMID:17964119 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:730951 | 6480464 | Mustard Gas results in increased expression of NOS2 protein | CTD | PMID:17524151 PMID:19397961 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of NOS2 protein | CTD | PMID:20659490 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:730951 | 6480464 | Roxithromycin inhibits the reaction [Mustard Gas results in increased expression of NOS2 protein] | CTD | PMID:17524151 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:730951 | 6480464 | Mustard Gas results in increased expression of NOS2 protein | CTD | PMID:17524151 |
| bisdemethoxycurcumin | multiple interactions | EXP | | 6480464 | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18838107 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:10996 | 6480464 | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18449507 PMID:19188055 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:10996 | 6480464 | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18449507 more ... |
| bisphenol A | multiple interactions | ISO | RGD:10996 | 6480464 | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:12860292 |
| bisphenol A | increases expression | ISO | RGD:10996 | 6480464 | bisphenol A results in increased expression of NOS2 mRNA | CTD | PMID:12233820 |
| bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of NOS2 protein | CTD | PMID:17434272 PMID:19362168 |
| bleomycin A2 | multiple interactions | ISO | RGD:10996 | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; more ... | CTD | PMID:15684285 |
| bleomycin A2 | increases expression | ISO | RGD:10996 | 6480464 | Bleomycin results in increased expression of NOS2 protein | CTD | PMID:15684285 |
| bleomycin A2 | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | CTD | PMID:19362168 |
| bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of NOS2 mRNA | CTD | PMID:17434272 |
| bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of NOS2 protein | CTD | PMID:19362168 PMID:17434272 |
| bleomycin A2 | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17434272 |
| bromocriptine | multiple interactions | ISO | RGD:10996 | 6480464 | Bromocriptine inhibits the reaction [SOD1 mutant form results in increased expression of NOS2 protein] | CTD | PMID:21867702 |
| budesonide | decreases expression | ISO | RGD:10996 | 6480464 | Budesonide results in decreased expression of NOS2 mRNA | CTD | PMID:17163412 |
| budesonide | multiple interactions | EXP | | 6480464 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | CTD | PMID:15734790 |
| cadmium atom | affects expression | EXP | | 6480464 | Cadmium affects the expression of NOS2 mRNA | CTD | PMID:16948784 |
| cadmium atom | increases expression | ISO | RGD:730951 | 6480464 | Cadmium results in increased expression of NOS2 mRNA | CTD | PMID:21694771 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Cadmium results in increased expression of NOS2 protein] | CTD | PMID:16226777 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Cadmium affects the expression of NOS2 mRNA] | CTD | PMID:16948784 |
| cadmium dichloride | increases expression | ISO | RGD:10996 | 6480464 | Cadmium Chloride results in increased expression of NOS2 protein | CTD | PMID:21620867 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Cadmium Chloride] results in increased expression of NOS2 protein | CTD | PMID:22898625 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NOS2 protein | CTD | PMID:21819444 PMID:22898625 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of NOS2 mRNA | CTD | PMID:16948784 PMID:21442002 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein] | CTD | PMID:21819444 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of NOS2 mRNA | CTD | PMID:21442002 PMID:16948784 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of NOS2 mRNA | CTD | PMID:20107868 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NOS2 protein | CTD | PMID:21819444 |
| cadmium dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | [Cadmium Chloride results in increased expression of HMOX1 protein] inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of NOS2 protein]; more ... | CTD | PMID:15220209 |
| cadmium dichloride | decreases expression | ISO | RGD:10996 | 6480464 | Cadmium Chloride results in decreased expression of NOS2 protein | CTD | PMID:15220209 |
| cadmium dichloride | multiple interactions | ISO | RGD:730951 | 6480464 | Cadmium Chloride inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased activity of NOS2 protein] | CTD | PMID:11076874 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of NOS2 mRNA | CTD | PMID:16948784 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Cadmium Chloride affects the expression of NOS2 mRNA] | CTD | PMID:16948784 |
| cadmium dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein] | CTD | PMID:21620867 |
| cadmium dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | Cadmium Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | CTD | PMID:18838692 |
| caffeine | multiple interactions | ISO | RGD:10996 | 6480464 | Caffeine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:22974838 |
| calcitriol | decreases expression | ISO | RGD:10996 | 6480464 | Calcitriol results in decreased expression of NOS2 protein | CTD | PMID:17600374 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA] | CTD | PMID:20599847 |
| candesartan | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Streptozocin results in increased expression of NOS2 protein] | CTD | PMID:16139267 |
| capsaicin | multiple interactions | ISO | RGD:730951 | 6480464 | Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]; more ... | CTD | PMID:19846903 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of NOS2 protein | CTD | PMID:20712533 PMID:11576744 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of NOS2 protein | CTD | PMID:11576744 PMID:20712533 |
| capsaicin | multiple interactions | EXP | | 6480464 | NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20712533 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of NOS2 mRNA | CTD | PMID:20712533 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of NOS2 | CTD | PMID:15681035 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:10671773 |
| capsaicin | multiple interactions | ISO | RGD:10996 | 6480464 | Capsaicin inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; more ... | CTD | PMID:14530214 |
| capsaicin | increases expression | ISO | RGD:730951 | 6480464 | Capsaicin results in increased expression of NOS2 protein | CTD | PMID:19846903 |
| carbamazepine | increases expression | EXP | | 6480464 | Carbamazepine results in increased expression of NOS2 protein | CTD | PMID:14511393 |
| carbamazepine | increases expression | EXP | | 6480464 | Carbamazepine results in increased expression of NOS2 mRNA | CTD | PMID:12429386 |
| carbaryl | multiple interactions | ISO | RGD:10996 | 6480464 | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15907790 |
| carbon monoxide | decreases expression | EXP | | 6480464 | Carbon Monoxide results in decreased expression of NOS2 protein | CTD | PMID:12201358 |
| carbon monoxide | multiple interactions | ISO | RGD:10996 | 6480464 | Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22046279 |
| carmustine | multiple interactions | EXP | | 6480464 | [Carmustine co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites]; more ... | CTD | PMID:7532384 |
| carmustine | decreases response to substance | EXP | | 6480464 | NOS2 protein results in decreased susceptibility to Carmustine | CTD | PMID:15965067 |
| carmustine | decreases response to substance | ISO | RGD:730951 | 6480464 | NOS2 protein results in decreased susceptibility to Carmustine | CTD | PMID:15110396 |
| carmustine | multiple interactions | ISO | RGD:730951 | 6480464 | [NOS2 protein results in increased chemical synthesis of S-Nitrosoglutathione] which results in decreased susceptibility to Carmustine | CTD | PMID:15110396 |
| carnosic acid | multiple interactions | ISO | RGD:10996 | 6480464 | salvin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:21375325 |
| carrageenan | multiple interactions | EXP | | 6480464 | Carrageenan inhibits the reaction [Raloxifene results in increased expression of NOS2 protein] | CTD | PMID:15860553 |
| carrageenan | multiple interactions | EXP | | 6480464 | Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:22330755 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of NOS2 protein | CTD | PMID:15860553 PMID:7542281 |
| carrageenan | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Carrageenan results in increased expression of NOS2 protein] | CTD | PMID:7542281 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of NOS2 protein | CTD | PMID:7542281 PMID:15860553 |
| carvedilol | multiple interactions | ISO | RGD:10996 | 6480464 | carvedilol promotes the reaction [wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:17159805 |
| carvedilol | multiple interactions | ISO | RGD:10996 | 6480464 | Atenolol inhibits the reaction [carvedilol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]]; more ... | CTD | PMID:19439816 |
| catechol | multiple interactions | ISO | RGD:10996 | 6480464 | catechol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18499097 |
| celecoxib | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA]] | CTD | PMID:21893697 |
| chalcone | multiple interactions | ISO | RGD:10996 | 6480464 | Chalcone analog inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; more ... | CTD | PMID:22155221 |
| chlorogenic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20026373 |
| chlorogenic acid | multiple interactions | EXP | | 6480464 | Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:23146752 |
| chondroitin sulfate | multiple interactions | ISO | RGD:730951 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein | CTD | PMID:17605605 |
| ciglitazone | multiple interactions | ISO | RGD:10996 | 6480464 | ciglitazone inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12847270 |
| ciglitazone | multiple interactions | ISO | RGD:10996 | 6480464 | ciglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12031542 |
| cilostazol | multiple interactions | ISO | RGD:10996 | 6480464 | cilostazol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21256160 |
| cisplatin | multiple interactions | ISO | RGD:730951 | 6480464 | Cisplatin inhibits the reaction [IFNG protein results in increased expression of and results in increased activity of NOS2 protein]; more ... | CTD | PMID:20959455 |
| cisplatin | multiple interactions | ISO | RGD:10996 | 6480464 | bicyclol inhibits the reaction [Cisplatin results in increased expression of NOS2 protein] | CTD | PMID:18956176 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of NOS2 protein | CTD | PMID:19535489 |
| cisplatin | increases expression | ISO | RGD:10996 | 6480464 | Cisplatin results in increased expression of NOS2 protein | CTD | PMID:18956176 more ... |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with sildenafil] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:19152827 |
| cisplatin | increases expression | ISO | RGD:10996 | 6480464 | Cisplatin results in increased expression of NOS2 protein | CTD | PMID:20510337 PMID:20942565 |
| cisplatin | multiple interactions | ISO | RGD:10996 | 6480464 | Thioctic Acid inhibits the reaction [Cisplatin results in increased expression of NOS2] | CTD | PMID:21763304 |
| cisplatin | multiple interactions | ISO | RGD:10996 | 6480464 | coenzyme Q10 inhibits the reaction [Cisplatin results in increased expression of NOS2 protein] | CTD | PMID:20510337 |
| cisplatin | multiple interactions | ISO | RGD:10996 | 6480464 | [Cisplatin results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:20942565 |
| cisplatin | increases expression | ISO | RGD:10996 | 6480464 | Cisplatin results in increased expression of NOS2 protein | CTD | PMID:20942565 PMID:20510337 |
| cisplatin | increases expression | ISO | RGD:10996 | 6480464 | Cisplatin results in increased expression of NOS2 | CTD | PMID:21763304 |
| cisplatin | increases degradation | ISO | RGD:730951 | 6480464 | Cisplatin results in increased degradation of NOS2 protein | CTD | PMID:20959455 |
| clofibrate | increases expression | ISO | RGD:10996 | 6480464 | Clofibrate results in increased expression of NOS2 mRNA | CTD | PMID:17585979 |
| clofibrate | increases expression | ISO | RGD:10996 | 6480464 | Clofibrate results in increased expression of NOS2 protein | CTD | PMID:16054168 |
| clofibrate | multiple interactions | ISO | RGD:730951 | 6480464 | Clofibrate inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter] | CTD | PMID:17492134 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of NOS2 protein | CTD | PMID:21098870 |
| clofibrate | multiple interactions | ISO | RGD:730951 | 6480464 | Clofibrate inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | CTD | PMID:12244038 |
| clofibrate | multiple interactions | ISO | RGD:10996 | 6480464 | PPARA protein affects the reaction [Clofibrate results in increased expression of NOS2 protein] | CTD | PMID:16054168 |
| cobalt atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of NOS2 mRNA | CTD | PMID:22198552 |
| cobalt dichloride | increases expression | ISO | RGD:10996 | 6480464 | cobaltous chloride results in increased expression of NOS2 mRNA | CTD | PMID:17169330 |
| cobalt dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | cobaltous chloride promotes the reaction [[[TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:8975779 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of NOS2 mRNA; more ... | CTD | PMID:18331222 |
| cobalt dichloride | increases expression | ISO | RGD:10996 | 6480464 | cobaltous chloride results in increased expression of NOS2 mRNA | CTD | PMID:17169330 PMID:22472292 |
| cobalt dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | [cobaltous chloride results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:22472292 |
| cobalt dichloride | increases expression | ISO | RGD:10996 | 6480464 | cobaltous chloride results in increased expression of NOS2 mRNA | CTD | PMID:22472292 PMID:17169330 |
| cobalt dichloride | increases expression | ISO | RGD:10996 | 6480464 | cobaltous chloride results in increased expression of NOS2 protein | CTD | PMID:22472292 |
| coenzyme Q10 | multiple interactions | ISO | RGD:10996 | 6480464 | coenzyme Q10 inhibits the reaction [Cisplatin results in increased expression of NOS2 protein] | CTD | PMID:20510337 |
| copper atom | increases expression | ISO | RGD:730951 | 6480464 | Copper results in increased expression of NOS2 mRNA; more ... | CTD | PMID:16962711 |
| copper atom | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | CTD | PMID:18779489 |
| copper atom | increases expression | ISO | RGD:10996 | 6480464 | Copper analog results in increased expression of NOS2 protein | CTD | PMID:22000994 |
| copper atom | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [Copper results in increased expression of NOS2 protein] | CTD | PMID:16987042 |
| copper atom | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA | CTD | PMID:20302851 |
| copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of NOS2 mRNA | CTD | PMID:16987042 |
| copper atom | multiple interactions | ISO | RGD:730951 | 6480464 | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16962711 |
| copper(0) | increases expression | ISO | RGD:730951 | 6480464 | Copper results in increased expression of NOS2 mRNA; more ... | CTD | PMID:16962711 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | CTD | PMID:18779489 |
| copper(0) | increases expression | ISO | RGD:10996 | 6480464 | Copper analog results in increased expression of NOS2 protein | CTD | PMID:22000994 |
| copper(0) | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [Copper results in increased expression of NOS2 protein] | CTD | PMID:16987042 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA | CTD | PMID:20302851 |
| copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of NOS2 mRNA | CTD | PMID:16987042 |
| copper(0) | multiple interactions | ISO | RGD:730951 | 6480464 | Plant Extracts inhibits the reaction [Copper results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16962711 |
| copper(2+) sulfate | decreases expression | ISO | RGD:730951 | 6480464 | Copper Sulfate results in decreased expression of NOS2 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] | CTD | PMID:8975779 |
| cortisol | multiple interactions | EXP | | 6480464 | Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17434272 |
| coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| crocidolite asbestos | increases expression | ISO | RGD:10996 | 6480464 | Asbestos, Crocidolite results in increased expression of NOS2 protein; more ... | CTD | PMID:12160931 PMID:11461780 |
| crocidolite asbestos | increases expression | ISO | RGD:10996 | 6480464 | Asbestos, Crocidolite results in increased expression of NOS2 protein; more ... | CTD | PMID:11461780 PMID:12160931 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of NOS2 mRNA; more ... | CTD | PMID:12051993 |
| crocidolite asbestos | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 gene mutant form inhibits the reaction [Asbestos, Crocidolite results in increased expression of TNF mRNA]; more ... | CTD | PMID:12160931 |
| crocidolite asbestos | multiple interactions | ISO | RGD:10996 | 6480464 | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 protein]; more ... | CTD | PMID:11461780 |
| curcumin | multiple interactions | ISO | RGD:730951 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; more ... | CTD | PMID:17640567 |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:19148301 more ... |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NOS2 mRNA] | CTD | PMID:22982865 |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:19188055 PMID:20712904 |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:19188055 PMID:18481332 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18368483 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16934299 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18838107 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 protein]; more ... | CTD | PMID:19481068 |
| curcumin | decreases activity | EXP | | 6480464 | Curcumin results in decreased activity of NOS2 protein | CTD | PMID:17461496 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934299 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16934299 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Dinitrochlorobenzene results in decreased expression of NOS2 protein] | CTD | PMID:17373747 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17827730 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Bleomycin results in increased expression of NOS2 protein]; more ... | CTD | PMID:17434272 |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18481332 PMID:19188055 |
| curcumin | affects expression | ISO | RGD:10996 | 6480464 | Curcumin affects the expression of NOS2 mRNA | CTD | PMID:18752423 |
| curcumin | multiple interactions | ISO | RGD:10996 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:19188055 |
| cycloheximide | multiple interactions | ISO | RGD:730951 | 6480464 | Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of NOS2 protein] | CTD | PMID:10760090 |
| cycloheximide | multiple interactions | ISO | RGD:730951 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS2 mRNA] | CTD | PMID:11007951 |
| cyclophosphamide | increases expression | ISO | RGD:10996 | 6480464 | Cyclophosphamide results in increased expression of NOS2 mRNA | CTD | PMID:10607705 PMID:21068404 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:11046124 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:19691848 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:18206168 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:18710439 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:11046124 more ... |
| cyclophosphamide | increases activity | EXP | | 6480464 | Cyclophosphamide results in increased activity of NOS2 protein | CTD | PMID:18296739 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:16879691 more ... |
| cyclophosphamide | increases activity | EXP | | 6480464 | Cyclophosphamide results in increased activity of NOS2 protein | CTD | PMID:15821589 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 mRNA | CTD | PMID:18710439 PMID:18206168 |
| cyclophosphamide | increases expression | ISO | RGD:10996 | 6480464 | Cyclophosphamide results in increased expression of NOS2 mRNA | CTD | PMID:21068404 PMID:10607705 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | rofecoxib inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] | CTD | PMID:16879691 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein]; more ... | CTD | PMID:18710439 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Cyclophosphamide results in increased activity of NOS2 protein] | CTD | PMID:15821589 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Cyclophosphamide results in increased activity of NOS2 protein] | CTD | PMID:18296739 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | ginkgolide B inhibits the reaction [Cyclophosphamide results in increased activity of NOS2 protein] | CTD | PMID:9006340 |
| cyclophosphamide | increases activity | EXP | | 6480464 | Cyclophosphamide results in increased activity of NOS2 protein | CTD | PMID:9006340 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 mRNA | CTD | PMID:18206168 PMID:18710439 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NOS2 protein | CTD | PMID:18710439 more ... |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | Bilirubin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18206168 |
| cyclosporin A | increases expression | ISO | RGD:730951 | 6480464 | Cyclosporine results in increased expression of NOS2 mRNA; more ... | CTD | PMID:10760090 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [[Adenosine Triphosphate results in increased expression of NOS2 protein] promotes the reaction [NOS2 protein binds to RELA protein]] | CTD | PMID:21464294 |
| cyclosporin A | multiple interactions | ISO | RGD:10996 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12144947 |
| cyclosporin A | multiple interactions | ISO | RGD:730951 | 6480464 | Cycloheximide inhibits the reaction [Cyclosporine results in increased expression of NOS2 protein] | CTD | PMID:10760090 |
| cyclosporin A | multiple interactions | ISO | RGD:730951 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12144947 |
| cyproterone acetate | decreases expression | EXP | | 6480464 | Cyproterone Acetate results in decreased expression of NOS2 mRNA | CTD | PMID:20463352 |
| cyproterone acetate | multiple interactions | EXP | | 6480464 | Cyproterone Acetate inhibits the reaction [testosterone enanthate results in increased expression of NOS2 protein] | CTD | PMID:23085480 |
| cyproterone acetate | multiple interactions | EXP | | 6480464 | Cyproterone Acetate inhibits the reaction [testosterone enanthate results in increased expression of NOS2 mRNA] | CTD | PMID:20463352 |
| cytochalasin D | multiple interactions | ISO | RGD:730951 | 6480464 | Cytochalasin D promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | CTD | PMID:12799187 |
| D-fructose 1,6-bisphosphate | multiple interactions | ISO | RGD:10996 | 6480464 | fructose-1,6-diphosphate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22227475 |
| D-fructose 1,6-bisphosphate | decreases degradation | ISO | RGD:10996 | 6480464 | fructose-1,6-diphosphate results in decreased degradation of NOS2 mRNA | CTD | PMID:22227475 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS2 protein | CTD | PMID:19587355 |
| D-glucose | increases expression | ISO | RGD:730951 | 6480464 | Glucose results in increased expression of NOS2 mRNA; more ... | CTD | PMID:22363694 |
| D-glucose | multiple interactions | ISO | RGD:10996 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; more ... | CTD | PMID:21925195 |
| D-glucose | multiple interactions | EXP | | 6480464 | PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; more ... | CTD | PMID:19587355 |
| daidzein | multiple interactions | ISO | RGD:10996 | 6480464 | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11308324 PMID:18274639 |
| daidzein | multiple interactions | ISO | RGD:10996 | 6480464 | daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:18274639 PMID:11308324 |
| daidzein | decreases activity | ISO | RGD:10996 | 6480464 | daidzein results in decreased activity of NOS2 protein | CTD | PMID:11308324 |
| DDE | decreases expression | ISO | RGD:10996 | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of NOS2 mRNA | CTD | PMID:12007859 |
| DDT | decreases expression | ISO | RGD:10996 | 6480464 | DDT metabolite results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:12007859 |
| DDT | increases expression | EXP | | 6480464 | DDT results in increased expression of NOS2 mRNA | CTD | PMID:11948501 |
| DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of NOS2 mRNA | CTD | PMID:11948501 |
| DDT | multiple interactions | ISO | RGD:10996 | 6480464 | [DDT co-treated with o,p'-DDT] results in decreased expression of NOS2 mRNA | CTD | PMID:12007859 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:10996 | 6480464 | Tetrahydrocannabinol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:8700141 |
| demethoxycurcumin | multiple interactions | EXP | | 6480464 | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18838107 |
| demethoxycurcumin | multiple interactions | ISO | RGD:10996 | 6480464 | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18449507 |
| desferrioxamine B | multiple interactions | EXP | | 6480464 | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Deferoxamine] | CTD | PMID:7532384 |
| desferrioxamine B | multiple interactions | ISO | RGD:10996 | 6480464 | [Deferoxamine results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide | CTD | PMID:18073202 |
| desferrioxamine B | increases expression | ISO | RGD:10996 | 6480464 | Deferoxamine results in increased expression of NOS2 mRNA | CTD | PMID:18073202 |
| dexamethasone | decreases expression | ISO | RGD:730951 | 6480464 | Dexamethasone results in decreased expression of NOS2 mRNA | CTD | PMID:12206003 |
| dexamethasone | decreases activity | EXP | | 6480464 | Dexamethasone results in decreased activity of NOS2 protein | CTD | PMID:9865512 PMID:9306416 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of NOS2 mRNA | CTD | PMID:8666049 PMID:9301432 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of NOS2 mRNA | CTD | PMID:7529313 PMID:10484530 |
| dexamethasone | decreases expression | ISO | RGD:10996 | 6480464 | Dexamethasone results in decreased expression of NOS2 protein | CTD | PMID:18030227 PMID:15106802 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | CTD | PMID:11454666 PMID:12628480 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of NOS2 protein | CTD | PMID:7529313 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of NOS2 mRNA | CTD | PMID:10484530 PMID:7529313 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of NOS2 mRNA | CTD | PMID:9301432 PMID:8666049 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | CTD | PMID:8666049 |
| dexamethasone | decreases activity | EXP | | 6480464 | Dexamethasone results in decreased activity of NOS2 protein | CTD | PMID:9306416 PMID:9865512 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11004044 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | CTD | PMID:12694877 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:10574470 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Endotoxins results in increased expression of NOS2 protein] | CTD | PMID:7537235 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Carrageenan results in increased expression of NOS2 protein] | CTD | PMID:7542281 |
| dexamethasone | affects expression | EXP | | 6480464 | Dexamethasone affects the expression of NOS2 protein | CTD | PMID:12604694 |
| dexamethasone | decreases expression | ISO | RGD:10996 | 6480464 | Dexamethasone results in decreased expression of NOS2 protein | CTD | PMID:15106802 PMID:18030227 |
| dexamethasone | decreases expression | ISO | RGD:10996 | 6480464 | Dexamethasone results in decreased expression of NOS2 mRNA | CTD | PMID:7524498 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased expression of NOS2 protein] | CTD | PMID:12628480 PMID:11454666 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16880258 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased activity of NOS2 protein] | CTD | PMID:12604694 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12794164 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | Dexamethasone inhibits the reaction [IL1 protein promotes the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]]; more ... | CTD | PMID:7540993 |
| dexamethasone | multiple interactions | ISO | RGD:10996 | 6480464 | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS2 protein | CTD | PMID:18030227 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 protein | CTD | PMID:16049979 more ... |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | monotropein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein] | CTD | PMID:23261679 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 protein | CTD | PMID:16049979 more ... |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of NOS2 protein | CTD | PMID:15459021 |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein] | CTD | PMID:20155626 |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein] | CTD | PMID:20132809 PMID:20155626 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 mRNA | CTD | PMID:15652231 PMID:19285099 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 protein | CTD | PMID:16049979 PMID:19285099 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 mRNA | CTD | PMID:19285099 PMID:15652231 |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; more ... | CTD | PMID:19285099 |
| dextran sulfate | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Dextran Sulfate | CTD | PMID:17449036 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 protein | CTD | PMID:16049979 |
| dextran sulfate | increases expression | ISO | RGD:10996 | 6480464 | Dextran Sulfate results in increased expression of NOS2 mRNA | CTD | PMID:15652231 |
| dextran sulfate | multiple interactions | ISO | RGD:10996 | 6480464 | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:17438113 |
| diarsenic trioxide | decreases expression | ISO | RGD:10996 | 6480464 | arsenic trioxide results in decreased expression of NOS2 mRNA | CTD | PMID:20693187 |
| diazepam | multiple interactions | ISO | RGD:10996 | 6480464 | Diazepam binds to and results in increased expression of NOS2 protein; more ... | CTD | PMID:18585439 |
| diazepam | increases expression | ISO | RGD:10996 | 6480464 | Diazepam results in increased expression of NOS2 protein | CTD | PMID:18585439 |
| diazepam | increases expression | EXP | | 6480464 | Diazepam results in increased expression of NOS2 mRNA | CTD | PMID:12429386 |
| diazoxide | multiple interactions | ISO | RGD:10996 | 6480464 | Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]; more ... | CTD | PMID:16257489 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 protein | CTD | PMID:19466570 PMID:19168511 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 mRNA | CTD | PMID:18594475 PMID:18816294 |
| diazoxide | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein] | CTD | PMID:19466570 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 mRNA | CTD | PMID:18816294 PMID:18594475 |
| diazoxide | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] | CTD | PMID:18594475 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 protein | CTD | PMID:19168511 PMID:19466570 |
| diazoxide | multiple interactions | EXP | | 6480464 | Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]; more ... | CTD | PMID:15927086 PMID:15795934 |
| diazoxide | multiple interactions | EXP | | 6480464 | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]]; more ... | CTD | PMID:15795934 PMID:15927086 |
| dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of NOS2 mRNA | CTD | PMID:21131444 |
| dichloromethane | multiple interactions | ISO | RGD:10996 | 6480464 | Methylene Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15563889 |
| dichlorvos | increases expression | EXP | | 6480464 | Dichlorvos results in increased expression of NOS2 mRNA; more ... | CTD | PMID:22817663 |
| diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of NOS2 mRNA | CTD | PMID:15135310 PMID:16944022 |
| diclofenac | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Diclofenac promotes the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:19393675 |
| diethyl maleate | multiple interactions | ISO | RGD:10996 | 6480464 | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; more ... | CTD | PMID:12774022 |
| diethyl maleate | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:9918918 |
| diethyl maleate | multiple interactions | EXP | | 6480464 | diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:7532384 |
| diflunisal | increases expression | EXP | | 6480464 | Diflunisal results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| dihydrolipoic acid | multiple interactions | ISO | RGD:10996 | 6480464 | dihydrolipoic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] | CTD | PMID:18838692 |
| dimercaprol | multiple interactions | ISO | RGD:10996 | 6480464 | [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; more ... | CTD | PMID:18838692 |
| dimethyl sulfoxide | decreases expression | ISO | RGD:730951 | 6480464 | Dimethyl Sulfoxide results in decreased expression of NOS2 mRNA | CTD | PMID:21878375 |
| diosmetin | multiple interactions | ISO | RGD:10996 | 6480464 | diosmetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934226 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of NOS2 mRNA; more ... | CTD | PMID:18331222 PMID:21914476 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of NOS2 mRNA; more ... | CTD | PMID:18331222 |
| dioxygen | multiple interactions | ISO | RGD:10996 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; more ... | CTD | PMID:21925195 |
| dioxygen | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21914476 |
| dipyridamole | multiple interactions | ISO | RGD:10996 | 6480464 | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16765938 |
| dipyridamole | increases expression | EXP | | 6480464 | Dipyridamole results in increased expression of NOS2 protein | CTD | PMID:12271277 |
| dipyridamole | increases expression | EXP | | 6480464 | Dipyridamole results in increased expression of NOS2 mRNA | CTD | PMID:8904084 |
| disodium selenite | multiple interactions | ISO | RGD:10996 | 6480464 | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of NOS2 protein]; more ... | CTD | PMID:18279804 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of NOS2 mRNA; more ... | CTD | PMID:19481068 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Sodium Selenite results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19481068 |
| disodium selenite | multiple interactions | ISO | RGD:10996 | 6480464 | Sodium Selenite inhibits the reaction [Streptozocin results in increased activity of NOS2 protein]; more ... | CTD | PMID:18789669 |
| disulfiram | affects expression | EXP | | 6480464 | Disulfiram affects the expression of NOS2 mRNA | CTD | PMID:17936468 |
| dobutamine | affects response to substance | ISO | RGD:730951 | 6480464 | NOS2 protein affects the susceptibility to Dobutamine | CTD | PMID:9396439 |
| dobutamine | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Dobutamine | CTD | PMID:11489778 |
| domperidone | multiple interactions | ISO | RGD:10996 | 6480464 | Domperidone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:21691039 |
| dopamine | multiple interactions | ISO | RGD:10996 | 6480464 | Atenolol inhibits the reaction [Dopamine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:19439816 |
| doxorubicin | increases expression | ISO | RGD:730951 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:18463201 PMID:15695394 |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 mRNA | CTD | PMID:12490132 more ... |
| doxorubicin | multiple interactions | ISO | RGD:10996 | 6480464 | tricarbonyldichlororuthenium (II) dimer inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA] | CTD | PMID:21443895 |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:10871338 more ... |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:19286953 more ... |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:10871338 more ... |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:17223128 PMID:20668052 |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 mRNA | CTD | PMID:12490132 PMID:19286953 |
| doxorubicin | increases expression | ISO | RGD:730951 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:15695394 PMID:18463201 |
| doxorubicin | multiple interactions | EXP | | 6480464 | N-benzyladriamycin-14-valerate inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] | CTD | PMID:20668052 |
| doxorubicin | multiple interactions | EXP | | 6480464 | oleuropein inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] | CTD | PMID:17223128 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20051877 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:20668052 PMID:17223128 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of NOS2 mRNA | CTD | PMID:12187937 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of NOS2 mRNA | CTD | PMID:20051877 |
| doxorubicin | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Doxorubicin | CTD | PMID:12591762 |
| doxorubicin | decreases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:19286953 |
| doxorubicin | multiple interactions | ISO | RGD:10996 | 6480464 | ferric nitrilotriacetate inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12490132 |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 protein | CTD | PMID:12490132 more ... |
| doxorubicin | increases expression | ISO | RGD:10996 | 6480464 | Doxorubicin results in increased expression of NOS2 mRNA | CTD | PMID:19286953 PMID:12490132 |
| doxorubicin | multiple interactions | ISO | RGD:730951 | 6480464 | Simvastatin promotes the reaction [Doxorubicin results in increased expression of NOS2 protein] | CTD | PMID:18463201 |
| doxorubicin | increases expression | ISO | RGD:730951 | 6480464 | Doxorubicin results in increased expression of NOS2 mRNA | CTD | PMID:15695394 |
| doxycycline | decreases expression | ISO | RGD:10996 | 6480464 | Doxycycline results in decreased expression of NOS2 protein | CTD | PMID:16365451 |
| doxycycline | multiple interactions | ISO | RGD:10996 | 6480464 | Doxycycline results in decreased stability of and results in decreased expression of NOS2 mRNA | CTD | PMID:16365451 |
| DPCPX | multiple interactions | ISO | RGD:10996 | 6480464 | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased expression of NOS2 protein] | CTD | PMID:10952960 |
| drospirenone | multiple interactions | ISO | RGD:730951 | 6480464 | [Ethinyl Estradiol co-treated with drospirenone] results in decreased expression of NOS2 mRNA | CTD | PMID:19631796 |
| edaravone | multiple interactions | ISO | RGD:10996 | 6480464 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18496239 |
| edaravone | increases degradation | EXP | | 6480464 | phenylmethylpyrazolone results in increased degradation of NOS2 mRNA | CTD | PMID:18078833 |
| edaravone | decreases expression | EXP | | 6480464 | phenylmethylpyrazolone results in decreased expression of NOS2 protein | CTD | PMID:18078833 |
| edaravone | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15629513 |
| edaravone | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [Pilocarpine results in increased expression of NOS2 protein] | CTD | PMID:18672383 |
| edaravone | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:18078833 |
| elemental selenium | multiple interactions | ISO | RGD:10996 | 6480464 | Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17630198 |
| elemental selenium | multiple interactions | ISO | RGD:10996 | 6480464 | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:14734799 |
| emodin | multiple interactions | EXP | | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] | CTD | PMID:18590720 |
| enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of NOS2 protein | CTD | PMID:21377515 |
| enalapril | decreases expression | ISO | RGD:10996 | 6480464 | Enalapril results in decreased expression of NOS2 protein | CTD | PMID:20720404 |
| enalapril | multiple interactions | ISO | RGD:10996 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of NOS2 protein | CTD | PMID:20720404 |
| endosulfan | multiple interactions | ISO | RGD:10996 | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Endosulfan results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17261270 |
| endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of NOS2 mRNA | CTD | PMID:20471459 |
| endosulfan | increases expression | ISO | RGD:10996 | 6480464 | Endosulfan results in increased expression of NOS2 mRNA | CTD | PMID:17261270 |
| esculetin | multiple interactions | ISO | RGD:10996 | 6480464 | esculetin promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16212885 |
| estriol | multiple interactions | ISO | RGD:10996 | 6480464 | Estriol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11063824 |
| estriol | decreases expression | ISO | RGD:10996 | 6480464 | Estriol results in decreased expression of NOS2 mRNA | CTD | PMID:21317386 |
| ethacrynic acid | multiple interactions | EXP | | 6480464 | Ethacrynic Acid promotes the reaction [Potassium Cyanide results in increased expression of NOS2 protein] | CTD | PMID:16933320 |
| ethanol | increases expression | ISO | RGD:730951 | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:18845238 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:18037914 more ... |
| ethanol | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Ethanol results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22525864 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NOS2 mRNA | CTD | PMID:19615717 PMID:22525864 |
| ethanol | increases expression | ISO | RGD:10996 | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:19063909 PMID:20016022 |
| ethanol | multiple interactions | ISO | RGD:10996 | 6480464 | SOD2 protein inhibits the reaction [Ethanol results in increased expression of NOS2 protein] | CTD | PMID:19063909 |
| ethanol | increases expression | ISO | RGD:10996 | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:20016022 PMID:19063909 |
| ethanol | multiple interactions | ISO | RGD:10996 | 6480464 | SOD2 protein affects the reaction [Ethanol results in increased expression of NOS2 protein] | CTD | PMID:20016022 |
| ethanol | multiple interactions | ISO | RGD:10996 | 6480464 | CNR1 gene mutant form affects the reaction [[Ethanol co-treated with Thioacetamide] results in increased expression of NOS2 mRNA] | CTD | PMID:21863215 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:19615717 PMID:18037914 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NOS2 protein | CTD | PMID:18037914 PMID:19615717 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NOS2 mRNA | CTD | PMID:19615717 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol results in decreased expression of and results in decreased activity of NOS2 protein; more ... | CTD | PMID:11173986 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:10231168 |
| ethanol | multiple interactions | ISO | RGD:10996 | 6480464 | Ethanol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18281171 |
| ethanol | multiple interactions | ISO | RGD:730951 | 6480464 | [Ethanol results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:18845238 |
| etoposide | increases expression | EXP | | 6480464 | Etoposide results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| eugenol | multiple interactions | ISO | RGD:10996 | 6480464 | Eugenol inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA] | CTD | PMID:21237301 |
| eugenol | multiple interactions | ISO | RGD:10996 | 6480464 | Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20043298 |
| eupatilin | multiple interactions | ISO | RGD:10996 | 6480464 | eupatilin inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of NOS2 protein]; more ... | CTD | PMID:21565208 |
| fenofibrate | multiple interactions | ISO | RGD:10996 | 6480464 | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:21300114 |
| fenoldopam | increases expression | EXP | | 6480464 | Fenoldopam results in increased expression of NOS2 protein | CTD | PMID:12180796 |
| ferroheme b | multiple interactions | ISO | RGD:730951 | 6480464 | Heme inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11076874 |
| ferulic acid | multiple interactions | ISO | RGD:10996 | 6480464 | ferulic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21291945 |
| ferulic acid | multiple interactions | ISO | RGD:10996 | 6480464 | ferulic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; more ... | CTD | PMID:22366099 |
| fisetin | multiple interactions | ISO | RGD:10996 | 6480464 | fisetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17177504 |
| flavone | multiple interactions | ISO | RGD:10996 | 6480464 | flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18274639 |
| flavonol | multiple interactions | ISO | RGD:10996 | 6480464 | Hemin promotes the reaction [3-hydroxyflavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:14563492 |
| flufenamic acid | multiple interactions | ISO | RGD:730951 | 6480464 | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:10866999 |
| flufenamic acid | increases expression | EXP | | 6480464 | Flufenamic Acid results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| fluoxetine | multiple interactions | ISO | RGD:10996 | 6480464 | Fluoxetine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:21575647 |
| fluoxetine | increases expression | ISO | RGD:10996 | 6480464 | Fluoxetine results in increased expression of NOS2 mRNA | CTD | PMID:16413968 |
| fluoxetine | multiple interactions | ISO | RGD:10996 | 6480464 | Fluoxetine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21467642 |
| flurbiprofen | increases expression | EXP | | 6480464 | Flurbiprofen results in increased expression of NOS2 mRNA | CTD | PMID:16944022 |
| flurbiprofen | multiple interactions | EXP | | 6480464 | Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:8528547 |
| flurbiprofen | multiple interactions | ISO | RGD:10996 | 6480464 | Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitrites]; more ... | CTD | PMID:11405284 |
| fluvoxamine | increases expression | EXP | | 6480464 | Fluvoxamine results in increased expression of NOS2 mRNA | CTD | PMID:12429386 |
| folic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Folic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:21528358 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of NOS2 mRNA | CTD | PMID:12679049 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of NOS2 mRNA | CTD | PMID:12679049 PMID:21983654 |
| formaldehyde | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Formaldehyde results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21983654 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of NOS2 protein | CTD | PMID:10090849 |
| fructose | multiple interactions | EXP | | 6480464 | [Fructose results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10090849 |
| fucoxanthin | multiple interactions | ISO | RGD:10996 | 6480464 | fucoxanthin analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22735499 |
| fulvestrant | multiple interactions | ISO | RGD:10996 | 6480464 | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]] | CTD | PMID:12860292 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of NOS2 protein] | CTD | PMID:11583108 |
| fulvestrant | multiple interactions | ISO | RGD:10996 | 6480464 | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:15256495 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [resveratrol results in increased activity of NOS2 protein] | CTD | PMID:17666920 |
| gabapentin | increases expression | EXP | | 6480464 | gabapentin results in increased expression of NOS2 protein | CTD | PMID:14511393 |
| gadodiamide hydrate | increases expression | ISO | RGD:730951 | 6480464 | gadodiamide results in increased expression of NOS2 protein | CTD | PMID:20959327 |
| gadolinium trichloride | increases expression | EXP | | 6480464 | gadolinium chloride results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| geldanamycin | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15583003 |
| geldanamycin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [geldanamycin results in decreased expression of NOS2 mRNA] | CTD | PMID:11835313 |
| geldanamycin | decreases expression | EXP | | 6480464 | geldanamycin results in decreased expression of NOS2 mRNA | CTD | PMID:11835313 |
| gemfibrozil | multiple interactions | ISO | RGD:730951 | 6480464 | Gemfibrozil inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12244038 |
| genistein | multiple interactions | ISO | RGD:10996 | 6480464 | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11308324 PMID:18274639 |
| genistein | multiple interactions | ISO | RGD:10996 | 6480464 | Genistein inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA] | CTD | PMID:20455021 |
| genistein | decreases expression | ISO | RGD:730951 | 6480464 | Genistein results in decreased expression of NOS2 mRNA | CTD | PMID:20706672 |
| genistein | multiple interactions | ISO | RGD:10996 | 6480464 | Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18274639 PMID:11308324 |
| genistein | decreases activity | ISO | RGD:10996 | 6480464 | Genistein results in decreased activity of NOS2 protein | CTD | PMID:11308324 |
| genistein | multiple interactions | ISO | RGD:10996 | 6480464 | Genistein inhibits the reaction [[TNF protein results in increased expression of NOS2 protein] which results in decreased expression of RETN mRNA] | CTD | PMID:18369347 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS2 protein | CTD | PMID:19587355 |
| glucose | increases expression | ISO | RGD:730951 | 6480464 | Glucose results in increased expression of NOS2 mRNA; more ... | CTD | PMID:22363694 |
| glucose | multiple interactions | ISO | RGD:10996 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; more ... | CTD | PMID:21925195 |
| glucose | multiple interactions | EXP | | 6480464 | PRKCB protein affects the reaction [Glucose results in increased expression of NOS2 protein]; more ... | CTD | PMID:19587355 |
| glutathione | multiple interactions | ISO | RGD:730951 | 6480464 | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of NOS2 protein]] | CTD | PMID:17640567 |
| glutathione | multiple interactions | ISO | RGD:10996 | 6480464 | Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of NOS2 protein] | CTD | PMID:21722719 |
| glutathione | multiple interactions | ISO | RGD:10996 | 6480464 | Glutathione inhibits the reaction [orazipone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | CTD | PMID:18039960 |
| glyburide | multiple interactions | ISO | RGD:10996 | 6480464 | Glyburide inhibits the reaction [Pinacidil inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]] | CTD | PMID:16257489 |
| glycochenodeoxycholic acid | increases expression | EXP | | 6480464 | Glycochenodeoxycholic Acid results in increased expression of NOS2 mRNA | CTD | PMID:15767249 |
| glycyrrhetinate | multiple interactions | ISO | RGD:10996 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein]; more ... | CTD | PMID:21644799 |
| glycyrrhetinic acid | multiple interactions | ISO | RGD:10996 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein]; more ... | CTD | PMID:21644799 |
| glycyrrhizinic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17917259 |
| glycyrrhizinic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Glycyrrhizic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21644799 |
| halothane | multiple interactions | EXP | | 6480464 | Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11506125 |
| halothane | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] | CTD | PMID:16965849 |
| halothane | increases expression | EXP | | 6480464 | Halothane results in increased expression of NOS2 protein | CTD | PMID:16965849 |
| hemin | multiple interactions | ISO | RGD:10996 | 6480464 | Hemin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:14563492 |
| herbimycin | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [[IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] which results in increased expression of NOS2 mRNA] | CTD | PMID:10825233 |
| hesperetin | multiple interactions | ISO | RGD:10996 | 6480464 | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 |
| hesperidin | multiple interactions | ISO | RGD:10996 | 6480464 | Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 |
| hesperidin | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22093918 |
| hexacosan-1-ol | multiple interactions | EXP | | 6480464 | 1-hexacosanol inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18528636 |
| histamine | multiple interactions | ISO | RGD:730951 | 6480464 | Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein]]; more ... | CTD | PMID:21145922 |
| histamine | increases phosphorylation | ISO | RGD:730951 | 6480464 | Histamine results in increased phosphorylation of NOS2 protein | CTD | PMID:21145922 |
| hyaluronic acid | affects expression | ISO | RGD:10996 | 6480464 | Hyaluronic Acid affects the expression of NOS2 mRNA | CTD | PMID:15597151 |
| hydrogen chloride | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Hydrochloric Acid | CTD | PMID:12646421 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:11574821 more ... |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:18573544 more ... |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:12771618 more ... |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:11574821 more ... |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:18573544 more ... |
| hydrogen chloride | multiple interactions | EXP | | 6480464 | S-methylisothiopseudouronium inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | CTD | PMID:18573544 |
| hydrogen chloride | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Hydrochloric Acid results in increased expression of NOS2 protein] | CTD | PMID:11574821 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of NOS2 protein | CTD | PMID:12771618 more ... |
| hydroquinone | multiple interactions | ISO | RGD:10996 | 6480464 | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15831208 |
| hydroquinone | multiple interactions | ISO | RGD:10996 | 6480464 | hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:15831208 PMID:19148301 |
| hydroquinone | decreases expression | ISO | RGD:10996 | 6480464 | hydroquinone results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:17464197 |
| ibuprofen | multiple interactions | ISO | RGD:10996 | 6480464 | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | CTD | PMID:11080519 |
| ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of NOS2 mRNA | CTD | PMID:11545620 PMID:11837731 |
| ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of NOS2 mRNA | CTD | PMID:11837731 PMID:11545620 |
| ibuprofen | increases activity | EXP | | 6480464 | Ibuprofen results in increased activity of NOS2 protein | CTD | PMID:11837731 |
| indomethacin | multiple interactions | EXP | | 6480464 | sulglicotide inhibits the reaction [Indomethacin results in increased expression of NOS2 protein] | CTD | PMID:17657623 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 PMID:16944022 |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:16944022 PMID:18306037 |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:10210152 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:11145282 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:10192188 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Formaldehyde results in increased expression of NOS2 mRNA] | CTD | PMID:21983654 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16944022 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:16133968 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:16169175 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:7529313 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:17657623 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:16818512 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:10210152 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:11145282 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:11991626 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:10210152 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11855677 more ... |
| indomethacin | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Indomethacin | CTD | PMID:15138204 PMID:10964977 |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11991626 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:18306037 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:11991626 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:7529313 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:7529313 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:10210152 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11991626 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | rebamipide inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11686837 |
| indomethacin | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:16169175 |
| indomethacin | multiple interactions | EXP | | 6480464 | Pentoxifylline inhibits the reaction [Indomethacin results in increased expression of NOS2 protein]; more ... | CTD | PMID:16133968 |
| indomethacin | multiple interactions | EXP | | 6480464 | ONO-NT 012 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:11991626 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 protein | CTD | PMID:11145282 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:10574470 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of NOS2 protein | CTD | PMID:10210152 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:10574470 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of NOS2 protein | CTD | PMID:15067210 |
| indomethacin | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:12568917 |
| indomethacin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:10671773 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:15610444 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18306037 |
| indomethacin | multiple interactions | EXP | | 6480464 | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:16818512 |
| indomethacin | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Indomethacin | CTD | PMID:10964977 PMID:15138204 |
| indomethacin | increases expression | ISO | RGD:10996 | 6480464 | Indomethacin results in increased expression of NOS2 mRNA | CTD | PMID:21691039 |
| indomethacin | decreases expression | ISO | RGD:10996 | 6480464 | Indomethacin results in decreased expression of NOS2 protein | CTD | PMID:11292070 |
| indomethacin | multiple interactions | ISO | RGD:10996 | 6480464 | Indomethacin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22107987 |
| indomethacin | multiple interactions | ISO | RGD:10996 | 6480464 | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | CTD | PMID:11080519 |
| indomethacin | multiple interactions | ISO | RGD:10996 | 6480464 | Domperidone inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21691039 |
| indomethacin | multiple interactions | ISO | RGD:10996 | 6480464 | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS2 protein | CTD | PMID:18030227 |
| indomethacin | multiple interactions | ISO | RGD:10996 | 6480464 | 3-methylsydnone-5-nitrosimine inhibits the reaction [NOS2 gene mutant form results in decreased susceptibility to Indomethacin] | CTD | PMID:10964977 |
| indomethacin | multiple interactions | EXP | | 6480464 | thiaton inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:11855677 |
| indomethacin | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:17202747 |
| iodixanol | decreases expression | EXP | | 6480464 | iodixanol results in decreased expression of NOS2 protein | CTD | PMID:21354280 |
| iopromide | decreases expression | EXP | | 6480464 | iopromide results in decreased expression of NOS2 protein | CTD | PMID:21354280 |
| iron atom | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:20302851 |
| iron atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of NOS2 mRNA | CTD | PMID:22198552 |
| iron atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Iron] results in increased expression of NOS2 protein | CTD | PMID:16728372 |
| iron atom | multiple interactions | ISO | RGD:10996 | 6480464 | Iron inhibits the reaction [Asbestos, Crocidolite results in increased expression of NOS2 protein]; more ... | CTD | PMID:11461780 |
| iron trichloride | multiple interactions | EXP | | 6480464 | [aluminum chloride co-treated with ferric chloride] results in increased expression of NOS2 protein | CTD | PMID:16728372 |
| isoeugenol | multiple interactions | ISO | RGD:10996 | 6480464 | isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17698059 |
| isoflurane | multiple interactions | EXP | | 6480464 | Ditiocarb inhibits the reaction [Isoflurane results in increased expression of NOS2 protein]; more ... | CTD | PMID:18708911 |
| isoflurane | increases expression | EXP | | 6480464 | Isoflurane results in increased expression of NOS2 protein | CTD | PMID:18708911 |
| isoliquiritigenin | multiple interactions | ISO | RGD:10996 | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of NOS2 protein] | CTD | PMID:19834288 |
| isoliquiritigenin | multiple interactions | ISO | RGD:10996 | 6480464 | isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein]; more ... | CTD | PMID:18295200 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein] | CTD | PMID:19466570 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 protein | CTD | PMID:19466570 PMID:19168511 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 mRNA | CTD | PMID:18594475 PMID:18816294 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 protein | CTD | PMID:19168511 PMID:19466570 |
| isoprenaline | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] | CTD | PMID:18594475 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NOS2 mRNA | CTD | PMID:18816294 PMID:18594475 |
| isorhamnetin | multiple interactions | ISO | RGD:10996 | 6480464 | 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:16213685 more ... |
| ivermectin | multiple interactions | ISO | RGD:10996 | 6480464 | Ivermectin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]; more ... | CTD | PMID:19168156 |
| jaspamide | multiple interactions | ISO | RGD:730951 | 6480464 | jasplakinolide promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | CTD | PMID:12799187 |
| kaempferol | decreases expression | ISO | RGD:730951 | 6480464 | kaempferol results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:17184768 |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11343698 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18274639 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934226 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:18274639 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18274639 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17177504 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11343698 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18274639 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17177504 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934226 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | CTD | PMID:11343698 |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:14563492 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:12512693 more ... |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | CTD | PMID:19352036 |
| kaempferol | multiple interactions | ISO | RGD:10996 | 6480464 | Hemin promotes the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:14563492 |
| kaempferol 3-O-glucoside | multiple interactions | ISO | RGD:10996 | 6480464 | astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22210036 |
| kainic acid | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17827730 |
| kainic acid | multiple interactions | ISO | RGD:10996 | 6480464 | PTGS2 protein inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:21589914 |
| kainic acid | increases expression | ISO | RGD:10996 | 6480464 | Kainic Acid results in increased expression of NOS2 mRNA | CTD | PMID:21589914 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of NOS2 mRNA | CTD | PMID:18375135 PMID:17827730 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of NOS2 mRNA | CTD | PMID:17827730 PMID:18375135 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of NOS2 protein | CTD | PMID:18375135 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA] | CTD | PMID:18779489 |
| L-ascorbic acid | decreases expression | EXP | | 6480464 | Ascorbic Acid results in decreased expression of NOS2 | CTD | PMID:19494560 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Isoproterenol results in increased expression of NOS2 protein] | CTD | PMID:19466570 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein]; more ... | CTD | PMID:17637181 |
| L-ascorbic acid | multiple interactions | ISO | RGD:730951 | 6480464 | Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of NOS2 protein] | CTD | PMID:17218764 |
| L-ascorbic acid | increases activity | ISO | RGD:730951 | 6480464 | Ascorbic Acid results in increased activity of NOS2 protein | CTD | PMID:20179380 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:15612528 |
| L-cysteine | multiple interactions | EXP | | 6480464 | Cysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:21308383 |
| L-methionine | multiple interactions | ISO | RGD:10996 | 6480464 | Methionine inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19739265 |
| lactacystin | multiple interactions | ISO | RGD:10996 | 6480464 | lactacystin inhibits the reaction [GW 7647 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:17891158 |
| lactacystin | multiple interactions | ISO | RGD:10996 | 6480464 | lactacystin inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; more ... | CTD | PMID:19376148 |
| lamotrigine | increases expression | EXP | | 6480464 | lamotrigine results in increased expression of NOS2 protein | CTD | PMID:14511393 |
| lead diacetate | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [lead acetate results in increased expression of NOS2 protein] | CTD | PMID:11454931 |
| lead diacetate | increases expression | ISO | RGD:10996 | 6480464 | lead acetate results in increased expression of NOS2 mRNA | CTD | PMID:22609695 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of NOS2 protein | CTD | PMID:11454931 |
| lead(0) | multiple interactions | EXP | | 6480464 | Vitamin E inhibits the reaction [Lead results in increased expression of NOS2 protein] | CTD | PMID:10523326 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of NOS2 protein | CTD | PMID:10523326 PMID:21364929 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of NOS2 protein | CTD | PMID:10523326 |
| leflunomide | multiple interactions | ISO | RGD:730951 | 6480464 | leflunomide inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:16393772 |
| leukotriene B4 | multiple interactions | ISO | RGD:10996 | 6480464 | Leukotriene B4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | CTD | PMID:11454666 |
| leukotriene C4 | multiple interactions | ISO | RGD:10996 | 6480464 | Leukotriene C4 inhibits the reaction [[Zymosan results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitrites] | CTD | PMID:11454666 |
| lipoic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Thioctic Acid inhibits the reaction [Cisplatin results in increased expression of NOS2] | CTD | PMID:21763304 |
| lisinopril dihydrate | multiple interactions | EXP | | 6480464 | [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20051877 |
| lithium atom | multiple interactions | EXP | | 6480464 | [Pilocarpine co-treated with Lithium] results in increased expression of NOS2 protein; more ... | CTD | PMID:20149694 |
| lithium chloride | increases expression | ISO | RGD:730951 | 6480464 | Lithium Chloride results in increased expression of NOS2 mRNA | CTD | PMID:19679347 |
| loganin | affects expression | ISO | RGD:10996 | 6480464 | loganin affects the expression of NOS2 protein | CTD | PMID:21864639 |
| losartan | affects expression | EXP | | 6480464 | Losartan affects the expression of NOS2 mRNA | CTD | PMID:12198324 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of NOS2 protein | CTD | PMID:16191423 PMID:21377515 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of NOS2 mRNA | CTD | PMID:16191423 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of NOS2 protein | CTD | PMID:21377515 PMID:16191423 |
| losartan | increases expression | EXP | | 6480464 | Losartan results in increased expression of NOS2 protein | CTD | PMID:18390819 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of NOS2 protein | CTD | PMID:21377515 |
| luteolin | multiple interactions | ISO | RGD:10996 | 6480464 | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:19426678 |
| luteolin | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18090225 |
| luteolin | multiple interactions | ISO | RGD:10996 | 6480464 | Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:16934226 |
| LY294002 | multiple interactions | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:17570326 |
| LY294002 | decreases expression | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NOS2 mRNA | CTD | PMID:10527657 |
| LY294002 | decreases activity | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of NOS2 protein | CTD | PMID:10527657 |
| LY294002 | multiple interactions | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Manganese results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16417967 |
| lycorine | multiple interactions | ISO | RGD:10996 | 6480464 | lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22155741 |
| m-xylene | increases expression | EXP | | 6480464 | 3-xylene results in increased expression of NOS2 protein | CTD | PMID:12717741 |
| magnesium atom | multiple interactions | EXP | | 6480464 | Magnesium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:15466955 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of NOS2 mRNA | CTD | PMID:20233601 |
| malonaldehyde | decreases expression | ISO | RGD:10996 | 6480464 | Malondialdehyde results in decreased expression of NOS2 protein | CTD | PMID:20940037 |
| maneb | multiple interactions | ISO | RGD:10996 | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20455021 |
| maneb | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:23159886 |
| maneb | increases expression | EXP | | 6480464 | Maneb results in increased expression of NOS2 mRNA | CTD | PMID:23159886 |
| manganese atom | multiple interactions | EXP | | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:16488514 |
| manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:20798247 |
| manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:20224926 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16417967 more ... |
| manganese atom | multiple interactions | EXP | | 6480464 | [Manganese results in increased abundance of Reactive Oxygen Species] promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15010209 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 more ... |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:18335517 PMID:16417967 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 more ... |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:16417967 PMID:18335517 |
| manganese atom | multiple interactions | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Manganese results in increased expression of NOS2 protein]; more ... | CTD | PMID:16417967 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:19812365 PMID:16551646 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 PMID:19812365 |
| manganese atom | decreases activity | EXP | | 6480464 | Manganese results in decreased activity of NOS2 protein | CTD | PMID:16488514 |
| manganese atom | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17827730 |
| manganese atom | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 |
| manganese(0) | multiple interactions | EXP | | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:16488514 |
| manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:20798247 |
| manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:20224926 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16417967 more ... |
| manganese(0) | multiple interactions | EXP | | 6480464 | [Manganese results in increased abundance of Reactive Oxygen Species] promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15010209 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 more ... |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:18335517 PMID:16417967 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 more ... |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 mRNA | CTD | PMID:16417967 PMID:18335517 |
| manganese(0) | multiple interactions | ISO | RGD:10996 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Manganese results in increased expression of NOS2 protein]; more ... | CTD | PMID:16417967 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:19812365 PMID:16551646 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 PMID:19812365 |
| manganese(0) | decreases activity | EXP | | 6480464 | Manganese results in decreased activity of NOS2 protein | CTD | PMID:16488514 |
| manganese(0) | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17827730 |
| manganese(0) | increases expression | ISO | RGD:10996 | 6480464 | Manganese results in increased expression of NOS2 protein | CTD | PMID:16551646 |
| manganese(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | Estradiol inhibits the reaction [manganese chloride results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21512103 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of NOS2 protein | CTD | PMID:18836210 PMID:20798247 |
| manganese(II) chloride | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to manganese chloride | CTD | PMID:22174044 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15010209 |
| manganese(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | NFKBIA protein affects the reaction [manganese chloride results in increased expression of NOS2 mRNA] | CTD | PMID:16168523 |
| manganese(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:15601679 |
| manganese(II) chloride | increases expression | ISO | RGD:10996 | 6480464 | manganese chloride results in increased expression of NOS2 protein | CTD | PMID:15601679 PMID:21512103 |
| manganese(II) chloride | increases expression | ISO | RGD:10996 | 6480464 | manganese chloride results in increased expression of NOS2 mRNA | CTD | PMID:16168523 PMID:21512103 |
| manganese(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased chemical synthesis of Reactive Oxygen Species]; more ... | CTD | PMID:19442826 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | Silymarin inhibits the reaction [manganese chloride results in increased expression of NOS2 mRNA] | CTD | PMID:22033861 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of NOS2 mRNA | CTD | PMID:18836210 PMID:22033861 |
| manganese(II) chloride | multiple interactions | ISO | RGD:10996 | 6480464 | manganese chloride promotes the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 protein] | CTD | PMID:21963524 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [manganese chloride results in increased expression of NOS2 protein] | CTD | PMID:18836210 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of NOS2 mRNA; more ... | CTD | PMID:18836210 |
| manganese(II) chloride | increases expression | ISO | RGD:10996 | 6480464 | manganese chloride results in increased expression of NOS2 mRNA; more ... | CTD | PMID:21512103 |
| mangiferin | multiple interactions | ISO | RGD:10996 | 6480464 | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | CTD | PMID:12694877 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [Galactosamine results in increased expression of NOS2 protein] | CTD | PMID:22310181 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12694877 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] | CTD | PMID:15381052 |
| mechlorethamine | increases expression | EXP | | 6480464 | Mechlorethamine results in increased expression of NOS2 protein | CTD | PMID:20883710 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Cadmium affects the expression of NOS2 mRNA]; more ... | CTD | PMID:16948784 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Gentamicins results in increased expression of NOS2 protein] | CTD | PMID:22526374 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin affects the reaction [Mercuric Chloride results in increased expression of NOS2 protein] | CTD | PMID:16801527 |
| melatonin | decreases expression | EXP | | 6480464 | Melatonin results in decreased expression of NOS2 mRNA | CTD | PMID:21442002 |
| melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of NOS2 mRNA | CTD | PMID:12074098 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Amphetamine results in increased expression of NOS2 mRNA] | CTD | PMID:18524487 |
| mercaptoethanol | multiple interactions | ISO | RGD:10996 | 6480464 | Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:15907790 |
| mercury dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; more ... | CTD | PMID:18838692 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of NOS2 protein | CTD | PMID:16801527 PMID:18441258 |
| mercury dichloride | increases expression | ISO | RGD:10996 | 6480464 | Mercuric Chloride results in increased expression of NOS2 mRNA | CTD | PMID:19501138 |
| mercury dichloride | multiple interactions | EXP | | 6480464 | Melatonin affects the reaction [Mercuric Chloride results in increased expression of NOS2 protein] | CTD | PMID:16801527 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of NOS2 protein | CTD | PMID:18441258 PMID:16801527 |
| mercury dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of NOS2 protein]; more ... | CTD | PMID:12175822 |
| methamphetamine | increases expression | ISO | RGD:10996 | 6480464 | Methamphetamine results in increased expression of NOS2 protein | CTD | PMID:19834288 |
| methamphetamine | multiple interactions | ISO | RGD:10996 | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of NOS2 protein] | CTD | PMID:19834288 |
| methimazole | multiple interactions | EXP | | 6480464 | Methimazole inhibits the reaction [Thioacetamide results in increased expression of NOS2 protein] | CTD | PMID:22564261 |
| methoctramine tetrahydrochloride | multiple interactions | EXP | | 6480464 | methoctramine inhibits the reaction [Mevinphos results in increased expression of NOS2 protein] | CTD | PMID:17395621 |
| methotrexate | multiple interactions | ISO | RGD:730951 | 6480464 | Methotrexate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:16393772 |
| methotrexate | decreases activity | EXP | | 6480464 | Methotrexate results in decreased activity of NOS2 protein | CTD | PMID:17666920 |
| methoxychlor | multiple interactions | ISO | RGD:10996 | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Methoxychlor results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15979571 |
| methoxychlor | increases expression | ISO | RGD:10996 | 6480464 | Methoxychlor results in increased expression of NOS2 mRNA | CTD | PMID:15979571 |
| methylglyoxal | affects response to substance | EXP | | 6480464 | NOS2 protein affects the susceptibility to Pyruvaldehyde | CTD | PMID:20621070 |
| methylglyoxal | increases expression | EXP | | 6480464 | Pyruvaldehyde results in increased expression of NOS2 protein | CTD | PMID:20621070 |
| methylglyoxal | multiple interactions | EXP | | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Pyruvaldehyde results in increased expression of NOS2 protein] | CTD | PMID:20621070 |
| metoclopramide | multiple interactions | ISO | RGD:10996 | 6480464 | Metoclopramide inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] | CTD | PMID:21691039 |
| metoprolol | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [Streptozocin results in increased expression of NOS2 protein] | CTD | PMID:18703049 |
| metronidazole | multiple interactions | EXP | | 6480464 | Metronidazole inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 |
| mevalonic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [[Lipopolysaccharides co-treated with TNF] results in increased expression of NOS2 mRNA]] | CTD | PMID:17729120 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IL1A results in decreased expression of NOS2 protein]]; more ... | CTD | PMID:15705589 |
| mevinphos | multiple interactions | EXP | | 6480464 | methoctramine inhibits the reaction [Mevinphos results in increased expression of NOS2 protein]; more ... | CTD | PMID:17395621 |
| mevinphos | increases expression | EXP | | 6480464 | Mevinphos results in increased expression of NOS2 protein | CTD | PMID:15111025 PMID:17395621 |
| mevinphos | increases expression | EXP | | 6480464 | Mevinphos results in increased expression of NOS2 mRNA | CTD | PMID:15111025 |
| mevinphos | increases expression | EXP | | 6480464 | Mevinphos results in increased expression of NOS2 protein | CTD | PMID:17395621 |
| miconazole | increases expression | EXP | | 6480464 | Miconazole results in increased expression of NOS2 mRNA | CTD | PMID:22262564 |
| microcystin-LR | multiple interactions | ISO | RGD:10996 | 6480464 | cyanoginosin LR inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:15712326 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:10231168 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15485488 |
| minocycline | multiple interactions | ISO | RGD:10996 | 6480464 | Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19285099 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [manganese chloride results in increased expression of NOS2 protein] | CTD | PMID:18836210 |
| monocrotaline | multiple interactions | EXP | | 6480464 | 4-chlorobenzyltetrahydroberberine inhibits the reaction [Monocrotaline results in increased expression of NOS2 mRNA] | CTD | PMID:16225752 |
| monocrotaline | increases expression | EXP | | 6480464 | Monocrotaline results in increased expression of NOS2 mRNA | CTD | PMID:22022327 PMID:16225752 |
| monocrotaline | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [Monocrotaline results in increased expression of NOS2 mRNA] | CTD | PMID:22022327 |
| monocrotaline | increases expression | EXP | | 6480464 | Monocrotaline results in increased expression of NOS2 mRNA | CTD | PMID:16225752 PMID:22022327 |
| monocrotaline | increases expression | EXP | | 6480464 | Monocrotaline results in increased expression of NOS2 mRNA | CTD | PMID:16225752 |
| monocrotaline | multiple interactions | ISO | RGD:10996 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA | CTD | PMID:21224054 |
| montelukast | multiple interactions | EXP | | 6480464 | montelukast inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 protein] | CTD | PMID:11698051 |
| morphine | increases activity | ISO | RGD:10996 | 6480464 | Morphine results in increased activity of NOS2 mRNA | CTD | PMID:11590188 |
| morphine | increases expression | ISO | RGD:10996 | 6480464 | Morphine results in increased expression of NOS2 mRNA | CTD | PMID:11590188 |
| morphine | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Morphine | CTD | PMID:19751225 |
| morphine | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha]; more ... | CTD | PMID:16325209 |
| morphine | increases expression | ISO | RGD:10996 | 6480464 | Morphine results in increased expression of NOS2 protein | CTD | PMID:15220775 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730951 | 6480464 | Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of NOS2 mRNA] | CTD | PMID:18830972 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:23159886 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:22227475 PMID:23268108 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA] | CTD | PMID:21237301 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:730951 | 6480464 | Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased expression of NOS2 protein] | CTD | PMID:21741372 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS2 protein]; more ... | CTD | PMID:16140881 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:9918918 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | CTD | PMID:7532384 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [orazipone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] | CTD | PMID:18039960 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22227475 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10996 | 6480464 | Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]] | CTD | PMID:19642688 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | sesamin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein] | CTD | PMID:19794909 PMID:22919443 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein | CTD | PMID:15686497 more ... |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | 2-(2,3-dicarboxycyclopropyl)glycine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein]; more ... | CTD | PMID:15686497 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein | CTD | PMID:19794909 PMID:22919443 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein] | CTD | PMID:22919443 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:10996 | 6480464 | Methylnitrosourea results in increased expression of NOS2 protein | CTD | PMID:16052507 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:21295105 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of NOS2 protein] | CTD | PMID:23194824 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of NOS2 protein | CTD | PMID:20501860 PMID:21554863 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of NOS2 protein | CTD | PMID:21554863 PMID:20501860 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] | CTD | PMID:21554863 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] | CTD | PMID:20501860 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | O-(chloroacetylcarbamoyl)fumagillol inhibits the reaction [Diethylnitrosamine results in increased activity of NOS2 protein]; more ... | CTD | PMID:16061884 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:20302851 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of NOS2 protein | CTD | PMID:20501860 |
| N-nitrosodiethylamine | increases activity | EXP | | 6480464 | Diethylnitrosamine results in increased activity of NOS2 protein | CTD | PMID:16061884 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:15135310 more ... |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:17724770 more ... |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Silymarin inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:17724770 PMID:16604421 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:16604421 more ... |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:17724770 more ... |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:15135310 more ... |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:16604421 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Silymarin inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:16604421 PMID:17724770 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Plant Preparations inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:17724770 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NOS2 mRNA | CTD | PMID:16604421 more ... |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:20422370 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:10996 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18449507 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:10996 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [manganese chloride promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:15601679 |
| naltrexone | decreases activity | ISO | RGD:730951 | 6480464 | Naltrexone results in decreased activity of NOS2 protein | CTD | PMID:15694688 |
| naproxen | increases expression | EXP | | 6480464 | Naproxen results in increased expression of NOS2 mRNA | CTD | PMID:16944022 |
| nickel atom | multiple interactions | EXP | | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:22198552 |
| nickel dichloride | multiple interactions | ISO | RGD:730951 | 6480464 | Acetylcysteine inhibits the reaction [nickel chloride results in decreased expression of NOS2 mRNA] | CTD | PMID:18830972 |
| nickel dichloride | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein promotes the reaction [nickel chloride promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased chemical synthesis of Nitric Oxide]]; more ... | CTD | PMID:8975779 |
| nickel dichloride | decreases expression | ISO | RGD:730951 | 6480464 | nickel chloride results in decreased expression of NOS2 mRNA | CTD | PMID:18830972 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of NOS2 mRNA | CTD | PMID:11114790 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | Niacin inhibits the reaction [Silicon Dioxide results in increased expression of and results in increased activity of NOS2 protein] | CTD | PMID:15182488 |
| nifedipine | multiple interactions | ISO | RGD:730951 | 6480464 | Nifedipine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11245857 |
| nimesulide | multiple interactions | ISO | RGD:10996 | 6480464 | nimesulide inhibits the reaction [bepafant inhibits the reaction [[Mycoplasma arthritidis mitogen results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]] | CTD | PMID:15242784 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NOS2 protein] | CTD | PMID:22940226 |
| nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of NOS2 mRNA | CTD | PMID:15135310 |
| nimesulide | decreases expression | ISO | RGD:10996 | 6480464 | nimesulide results in decreased expression of NOS2 | CTD | PMID:15892897 |
| nimesulide | multiple interactions | ISO | RGD:10996 | 6480464 | nimesulide inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22107987 |
| nitric oxide | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:17651055 |
| nitric oxide | increases chemical synthesis | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18481332 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | chromous chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; more ... | CTD | PMID:8975779 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17067557 PMID:18507870 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12144947 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Melitten inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:15529353 PMID:17570326 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17067557 PMID:18507870 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:17067557 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:15529353 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:17067557 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Bee Venoms inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:15529353 more ... |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:18507870 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10188978 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Benzene promotes the reaction [[CSF1 protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 mRNA]] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:8193360 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:18507870 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Caffeine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:22974838 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:22101131 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10188978 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; more ... | CTD | PMID:20527891 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | naringenin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10188978 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10188978 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10086329 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20708382 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [NOS2 protein results in increased chemical synthesis of Nitric Oxide] which results in decreased susceptibility to endothelium-dependent hyperpolarization factor | CTD | PMID:20035746 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Taurocholic Acid results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:16389574 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12612912 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12133974 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:10086329 |
| nitric oxide | multiple interactions | EXP | | 6480464 | NOS2 protein affects the reaction [Adenosine Triphosphate results in increased abundance of Nitric Oxide] | CTD | PMID:21464294 |
| nitric oxide | increases expression | ISO | RGD:730951 | 6480464 | Nitric Oxide results in increased expression of NOS2 mRNA; more ... | CTD | PMID:18796497 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Deferoxamine results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide | CTD | PMID:18073202 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20417174 PMID:20527891 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:20712904 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [4-coumaric acid results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:22366099 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Pyrazines inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:22342441 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20558268 PMID:22342441 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | 1,2-naphthoquinone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21139339 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12612912 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of NOS2 mRNA] | CTD | PMID:21983654 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11286988 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Indomethacin results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:16944022 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11500931 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20708382 PMID:20848677 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [NOS2 protein results in increased abundance of Nitric Oxide] affects the susceptibility to [IL1B protein co-treated with TNF protein co-treated with IFNG protein] | CTD | PMID:10909967 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 protein] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12612912 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [[TNF protein co-treated with IFNG protein] affects the expression of NOS2 mRNA] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12612912 PMID:12612912 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17448908 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18078833 more ... |
| nitric oxide | increases chemical synthesis | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20417174 PMID:18481332 |
| nitric oxide | increases abundance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased abundance of Nitric Oxide | CTD | PMID:10909967 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Nitric Oxide results in increased expression of HMOX1 protein] inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of NOS2 protein]; more ... | CTD | PMID:15220209 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20023007 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:8652180 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [cobaltous chloride results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:22472292 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | cilostazol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:21256160 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17448908 PMID:18838107 |
| nitric oxide | increases chemical synthesis | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18481332 PMID:20417174 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20708382 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:20417174 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | capsazepine inhibits the reaction [[IFNG protein results in increased abundance of Nitric Oxide] which results in increased expression of NOS2 protein]; more ... | CTD | PMID:14530214 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | HMOX1 protein promotes the reaction [[Raloxifene results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:20888885 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:9530173 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11286988 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | praeruptorin A inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20842678 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Plant Extracts inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20848677 PMID:20708382 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11518563 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Fluoxetine analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21467642 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20023007 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Drugs, Chinese Herbal inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20558268 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Carthamus yellow inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:20848677 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:8652180 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21284090 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12144947 more ... |
| nitric oxide | increases abundance | ISO | RGD:730951 | 6480464 | NOS2 protein results in increased abundance of Nitric Oxide | CTD | PMID:9288130 PMID:9706149 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:7705308 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12133974 PMID:21893401 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11518563 PMID:11500931 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11919077 PMID:12162464 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:22101131 PMID:22227475 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12144947 more ... |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:20004183 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:16376947 |
| nitric oxide | multiple interactions | EXP | | 6480464 | wuzi yanzong analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21893401 |
| nitric oxide | multiple interactions | EXP | | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:9788894 |
| nitric oxide | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18078833 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:7705308 more ... |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18838107 PMID:17448908 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [NOS2 protein results in increased abundance of Nitric Oxide] which results in increased expression of TP53 protein | CTD | PMID:9743513 |
| nitric oxide | increases abundance | EXP | | 6480464 | NOS2 protein results in increased abundance of Nitric Oxide | CTD | PMID:9743513 |
| nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of NOS2 protein | CTD | PMID:15249212 |
| nitric oxide | affects expression | EXP | | 6480464 | Nitric Oxide deficiency affects the expression of NOS2 protein | CTD | PMID:19631198 |
| nitric oxide | multiple interactions | EXP | | 6480464 | Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:17448908 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:21893401 PMID:12133974 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:7519435 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IL1B protein results in increased expression of and results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:11530235 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Gentamicins results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:17312373 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:7519435 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Fructose results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10090849 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ethanol results in decreased expression of and results in decreased activity of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:11173986 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Endotoxins results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:15364003 |
| nitric oxide | multiple interactions | EXP | | 6480464 | Endotoxins inhibits the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:8652180 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [zoledronic acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:19818098 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [TNF protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:18369347 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Thiourea analog results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:17467989 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] which results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:17630198 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [S100B protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:16376947 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11500931 PMID:11518563 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | quercetin pentaacetate inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:11500931 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12162464 PMID:11919077 |
| nitric oxide | increases chemical synthesis | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18481332 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Nicotine results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:17135361 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12162464 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:21926162 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11500931 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide | CTD | PMID:22227475 PMID:22101131 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Ginkgo biloba extract 761 inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:11518563 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:12144947 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Cisplatin results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:20942565 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | bisphenol A inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12860292 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2] which results in increased abundance of Nitric Oxide] | CTD | PMID:22155221 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | bepafant inhibits the reaction [[Mycoplasma arthritidis mitogen results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:15242784 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:22227475 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]; more ... | CTD | PMID:17135264 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:22101131 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [Acetaminophen results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:10860828 |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:12847270 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [Trichloroethylene results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17719164 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:22251620 |
| nitric oxide | increases chemical synthesis | ISO | RGD:730951 | 6480464 | NOS2 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10450786 |
| nitric oxide | increases abundance | ISO | RGD:730951 | 6480464 | NOS2 protein results in increased abundance of Nitric Oxide | CTD | PMID:9706149 PMID:9288130 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Nicotine promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide] | CTD | PMID:16927020 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | lornoxicam inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10450786 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | IL1B protein promotes the reaction [NOS2 protein results in increased abundance of Nitric Oxide] | CTD | PMID:8982730 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:16393772 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]] | CTD | PMID:9755104 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; more ... | CTD | PMID:9706149 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | Cyclosporine inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:12144947 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [Acetaldehyde results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:18845238 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12133974 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10996 | 6480464 | [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:11020457 |
| nitric oxide | multiple interactions | ISO | RGD:730951 | 6480464 | [resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:12060119 PMID:22251620 |
| nitrogen dioxide | increases expression | ISO | RGD:10996 | 6480464 | Nitrogen Dioxide results in increased expression of NOS2 mRNA | CTD | PMID:10715624 |
| nitroglycerin | decreases expression | ISO | RGD:730951 | 6480464 | Nitroglycerin results in decreased expression of NOS2 mRNA | CTD | PMID:12206003 |
| nitroglycerin | decreases expression | EXP | | 6480464 | Nitroglycerin results in decreased expression of NOS2 protein | CTD | PMID:14732477 |
| nitroglycerin | increases expression | EXP | | 6480464 | Nitroglycerin results in increased expression of NOS2 protein; more ... | CTD | PMID:11701602 |
| nitroglycerin | multiple interactions | EXP | | 6480464 | NOS2 protein affects the reaction [Nitroglycerin results in increased expression of CALCA mRNA] | CTD | PMID:14729435 |
| nitroprusside | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Nitroprusside] | CTD | PMID:11498454 |
| nitroprusside | increases expression | ISO | RGD:10996 | 6480464 | Nitroprusside results in increased expression of NOS2 protein | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:10996 | 6480464 | [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17067557 PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:10996 | 6480464 | Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:10996 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:730951 | 6480464 | [Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17067557 PMID:18507870 |
| nitroprusside | increases expression | ISO | RGD:730951 | 6480464 | Nitroprusside results in increased expression of NOS2 protein | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:730951 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:730951 | 6480464 | Melitten inhibits the reaction [[Nitroprusside results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:730951 | 6480464 | Nitroprusside inhibits the reaction [[IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; more ... | CTD | PMID:11076874 |
| nitroprusside | decreases activity | ISO | RGD:730951 | 6480464 | Nitroprusside results in decreased activity of NOS2 protein | CTD | PMID:11076874 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of NOS2 protein | CTD | PMID:19414514 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of NOS2 mRNA | CTD | PMID:15994020 |
| ochratoxin A | multiple interactions | ISO | RGD:10996 | 6480464 | ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18647641 |
| ochratoxin A | multiple interactions | EXP | | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15994020 |
| ochratoxin A | increases expression | ISO | RGD:10996 | 6480464 | ochratoxin A results in increased expression of NOS2 protein | CTD | PMID:18647641 |
| oroxylin A | multiple interactions | ISO | RGD:10996 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22101131 |
| oxcarbazepine | increases expression | EXP | | 6480464 | oxcarbazepine results in increased expression of NOS2 protein | CTD | PMID:14511393 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | MT1 protein affects the reaction [Ozone affects the expression of NOS2 protein]; more ... | CTD | PMID:18929643 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:10022268 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:11919077 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:7705308 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:8666049 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:7705308 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:12855403 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:9788894 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:9788894 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:9788894 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:10715624 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:12162464 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:7705308 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:7705308 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:9788894 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:12162464 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:20826374 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:16330353 more ... |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:11919077 PMID:12162464 |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:10715624 more ... |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:8666049 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:15064226 more ... |
| ozone | multiple interactions | EXP | | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Ozone results in increased expression of NOS2 protein]; more ... | CTD | PMID:9788894 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:10022268 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:7705308 more ... |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:7705308 more ... |
| ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of NOS2 mRNA | CTD | PMID:17662977 |
| ozone | multiple interactions | EXP | | 6480464 | Ozone promotes the reaction [IFNG protein results in increased expression of NOS2 protein]; more ... | CTD | PMID:7519435 |
| ozone | multiple interactions | EXP | | 6480464 | Endotoxins inhibits the reaction [Ozone results in increased expression of NOS2 protein]; more ... | CTD | PMID:8652180 |
| ozone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of NOS2 mRNA] | CTD | PMID:8666049 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | TLR4 protein affects the reaction [Ozone results in increased expression of NOS2 mRNA] | CTD | PMID:11159012 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | SOD1 protein inhibits the reaction [Ozone results in increased expression of NOS2 protein] | CTD | PMID:12855403 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12162464 PMID:11919077 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Dinoprostone; more ... | CTD | PMID:11919077 |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 protein | CTD | PMID:12855403 more ... |
| ozone | increases expression | ISO | RGD:10996 | 6480464 | Ozone results in increased expression of NOS2 mRNA | CTD | PMID:11159012 PMID:10715624 |
| ozone | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Ozone | CTD | PMID:11159012 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:12162464 |
| ozone | multiple interactions | ISO | RGD:10996 | 6480464 | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]]; more ... | CTD | PMID:15064226 |
| palmitic acid | increases expression | ISO | RGD:10996 | 6480464 | Palmitic Acid results in increased expression of NOS2 mRNA | CTD | PMID:18323514 |
| palmitic acid | multiple interactions | ISO | RGD:730951 | 6480464 | rosiglitazone inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:18155663 |
| palmitic acid | increases expression | ISO | RGD:730951 | 6480464 | Palmitic Acid results in increased expression of NOS2 mRNA | CTD | PMID:18155663 |
| palmitic acid | multiple interactions | ISO | RGD:10996 | 6480464 | Pravastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18323514 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:19739265 more ... |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Arsenic results in decreased expression of NOS2 mRNA] | CTD | PMID:22120977 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of NOS2 protein | CTD | PMID:22575169 |
| paracetamol | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:22093918 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:19922764 PMID:22093918 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:19784758 PMID:22093918 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein]; more ... | CTD | PMID:20423716 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:11826401 more ... |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of NOS2 protein] | CTD | PMID:22461450 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:12392966 more ... |
| paracetamol | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:11826401 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:12392966 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:19739265 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:19922764 |
| paracetamol | multiple interactions | EXP | | 6480464 | arjunolic acid inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] | CTD | PMID:19922764 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:19739265 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:12392966 more ... |
| paracetamol | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:14550746 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NOS2 mRNA | CTD | PMID:16172162 PMID:19784758 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:12392966 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:12153990 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:19784758 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NOS2 mRNA | CTD | PMID:19784758 PMID:16172162 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of NOS2 mRNA | CTD | PMID:19784758 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | CTD | PMID:14557383 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | pimagedine inhibits the reaction [NOS2 protein results in increased susceptibility to Acetaminophen]; more ... | CTD | PMID:14550746 |
| paracetamol | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:14550746 more ... |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein inhibits the reaction [Acetaminophen results in increased expression of CTGF mRNA]; more ... | CTD | PMID:12392966 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19739265 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | CXCR2 protein affects the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | CTD | PMID:16552707 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | IL10 protein inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | CTD | PMID:11826401 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | IFNG protein promotes the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | CTD | PMID:12153990 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:12547406 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:16552707 more ... |
| paracetamol | increases activity | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased activity of NOS2 protein | CTD | PMID:12547406 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | [Acetaminophen results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:10860828 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | Acetaminophen inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:12774022 |
| paracetamol | decreases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:10860828 |
| paracetamol | multiple interactions | ISO | RGD:10996 | 6480464 | 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Acetaminophen results in increased activity of NOS2 protein]; more ... | CTD | PMID:12547406 |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:19739265 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 mRNA | CTD | PMID:11826401 more ... |
| paracetamol | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:11826401 more ... |
| paracetamol | increases expression | ISO | RGD:10996 | 6480464 | Acetaminophen results in increased expression of NOS2 protein | CTD | PMID:19739265 more ... |
| paraquat | increases expression | ISO | RGD:10996 | 6480464 | Paraquat results in increased expression of NOS2 mRNA | CTD | PMID:17215068 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOS2 protein | CTD | PMID:20004239 PMID:20388547 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOS2 mRNA | CTD | PMID:20388547 PMID:23159886 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOS2 mRNA | CTD | PMID:23159886 |
| paraquat | decreases expression | ISO | RGD:10996 | 6480464 | Paraquat results in decreased expression of NOS2 mRNA | CTD | PMID:21688324 |
| paraquat | multiple interactions | ISO | RGD:10996 | 6480464 | [Paraquat co-treated with APOD gene mutant form] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:21688324 |
| paraquat | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:23159886 |
| paraquat | multiple interactions | ISO | RGD:10996 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:20455021 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOS2 protein | CTD | PMID:20004239 |
| paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of NOS2 mRNA | CTD | PMID:12935482 |
| paricalcitol | decreases expression | ISO | RGD:10996 | 6480464 | paricalcitol results in decreased expression of NOS2 protein | CTD | PMID:20720404 |
| paricalcitol | multiple interactions | ISO | RGD:10996 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of NOS2 protein | CTD | PMID:20720404 |
| pelargonidin | multiple interactions | ISO | RGD:10996 | 6480464 | pelargonidin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:18274639 |
| peroxynitrous acid | affects abundance | ISO | RGD:730951 | 6480464 | NOS2 protein affects the abundance of Peroxynitrous Acid | CTD | PMID:15694688 |
| peroxynitrous acid | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Peroxynitrous Acid | CTD | PMID:11919077 |
| phenethyl isothiocyanate | decreases expression | ISO | RGD:10996 | 6480464 | phenethyl isothiocyanate results in decreased expression of NOS2 mRNA | CTD | PMID:16373530 |
| phenylephrine | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Acetylcholine]; more ... | CTD | PMID:11498454 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 protein]; more ... | CTD | PMID:15753950 |
| phenylephrine | increases activity | EXP | | 6480464 | Phenylephrine results in increased activity of NOS2 protein | CTD | PMID:15753950 |
| phenylephrine | decreases response to substance | EXP | | 6480464 | NOS2 protein results in decreased susceptibility to Phenylephrine | CTD | PMID:15902277 |
| phenylephrine | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Phenylephrine | CTD | PMID:11498454 |
| phenytoin | multiple interactions | ISO | RGD:10996 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730951 | 6480464 | Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20559769 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10996 | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein]; more ... | CTD | PMID:18551458 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein | CTD | PMID:18551458 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:18683823 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:20026373 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:19539808 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10996 | 6480464 | Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20026373 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:19539808 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730951 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA | CTD | PMID:20004183 PMID:20559769 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:20043298 more ... |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10996 | 6480464 | Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20043298 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:18683823 PMID:19539808 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730951 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:20004183 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730951 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA | CTD | PMID:20559769 PMID:20004183 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:730951 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:20004183 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] | CTD | PMID:14534150 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein; more ... | CTD | PMID:14700523 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10996 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein | CTD | PMID:19539808 PMID:18683823 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10996 | 6480464 | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] | CTD | PMID:19539808 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10996 | 6480464 | gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein]; more ... | CTD | PMID:18683823 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:730951 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA | CTD | PMID:20559769 |
| pioglitazone | decreases expression | ISO | RGD:10996 | 6480464 | pioglitazone results in decreased expression of NOS2 mRNA | CTD | PMID:15817521 |
| pioglitazone | multiple interactions | ISO | RGD:730951 | 6480464 | pioglitazone inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter] | CTD | PMID:17492134 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [Endotoxins results in increased expression of NOS2 protein] | CTD | PMID:15364003 |
| pirinixic acid | multiple interactions | ISO | RGD:10996 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:17891158 |
| pirinixic acid | multiple interactions | ISO | RGD:10996 | 6480464 | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:21300114 PMID:17891158 |
| pirinixic acid | multiple interactions | ISO | RGD:10996 | 6480464 | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17891158 PMID:21300114 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of NOS2 mRNA | CTD | PMID:16940010 |
| pirinixic acid | decreases expression | ISO | RGD:10996 | 6480464 | pirinixic acid results in decreased expression of NOS2 mRNA | CTD | PMID:17426115 |
| pitavastatin | multiple interactions | ISO | RGD:10996 | 6480464 | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18323514 |
| polymyxin B2 | multiple interactions | EXP | | 6480464 | Polymyxin B inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:12568917 |
| potassium chloride | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Potassium Chloride | CTD | PMID:11498454 |
| potassium cyanide | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine promotes the reaction [Potassium Cyanide results in increased expression of NOS2 protein]; more ... | CTD | PMID:16933320 |
| potassium cyanide | increases expression | EXP | | 6480464 | Potassium Cyanide results in increased expression of NOS2 mRNA; more ... | CTD | PMID:16933320 |
| potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of NOS2 protein | CTD | PMID:18441258 |
| pravastatin | multiple interactions | ISO | RGD:10996 | 6480464 | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18323514 |
| prazosin | multiple interactions | EXP | | 6480464 | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15753950 |
| prazosin | multiple interactions | ISO | RGD:10996 | 6480464 | Prazosin inhibits the reaction [carvedilol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:19439816 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of NOS2 mRNA | CTD | PMID:19162173 |
| pristane | increases expression | ISO | RGD:10996 | 6480464 | pristane results in increased expression of NOS2 mRNA | CTD | PMID:15075356 |
| progesterone | affects response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein affects the susceptibility to Progesterone | CTD | PMID:15869954 |
| progesterone | multiple interactions | ISO | RGD:10996 | 6480464 | Progesterone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11063824 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of NOS2 mRNA | CTD | PMID:16399999 |
| propofol | multiple interactions | ISO | RGD:10996 | 6480464 | Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19573522 |
| propofol | multiple interactions | EXP | | 6480464 | Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] | CTD | PMID:16965849 |
| prostaglandin A1 | multiple interactions | ISO | RGD:10996 | 6480464 | prostaglandin A1 inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:12031542 |
| prostaglandin E1 | multiple interactions | EXP | | 6480464 | Alprostadil inhibits the reaction [Galactosamine results in increased expression of NOS2 promoter]; more ... | CTD | PMID:15565661 |
| prostaglandin E1 | increases expression | EXP | | 6480464 | Alprostadil results in increased expression of NOS2 mRNA; more ... | CTD | PMID:15189274 PMID:15565661 |
| prostaglandin E1 | multiple interactions | EXP | | 6480464 | Galactosamine promotes the reaction [Alprostadil results in increased expression of NOS2 protein] | CTD | PMID:15189274 |
| prostaglandin E1 | increases expression | EXP | | 6480464 | Alprostadil results in increased expression of NOS2 promoter | CTD | PMID:15565661 |
| prostaglandin E1 | increases expression | EXP | | 6480464 | Alprostadil results in increased expression of NOS2 mRNA; more ... | CTD | PMID:15565661 PMID:15189274 |
| prostaglandin E2 | multiple interactions | ISO | RGD:10996 | 6480464 | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | CTD | PMID:16325209 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; more ... | CTD | PMID:16944022 |
| prostaglandin E2 | multiple interactions | ISO | RGD:730951 | 6480464 | honokiol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:21147091 |
| prostaglandin E2 | multiple interactions | ISO | RGD:10996 | 6480464 | [Ozone results in increased expression of NOS2 protein] which results in increased abundance of Dinoprostone | CTD | PMID:11919077 |
| prostaglandin E2 | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 results in increased susceptibility to Dinoprostone | CTD | PMID:15491851 |
| protoporphyrin | multiple interactions | ISO | RGD:10996 | 6480464 | protoporphyrin IX inhibits the reaction [Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] | CTD | PMID:21827494 |
| pterostilbene | multiple interactions | ISO | RGD:10996 | 6480464 | pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA] | CTD | PMID:22698256 |
| pterostilbene | multiple interactions | ISO | RGD:10996 | 6480464 | pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2] | CTD | PMID:22842666 |
| pterostilbene | multiple interactions | ISO | RGD:10996 | 6480464 | pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein] | CTD | PMID:18551458 |
| pterostilbene | multiple interactions | ISO | RGD:10996 | 6480464 | pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 protein]; more ... | CTD | PMID:20681671 PMID:21355597 |
| pterostilbene | multiple interactions | ISO | RGD:730951 | 6480464 | pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:19549798 |
| putrescine | multiple interactions | ISO | RGD:10996 | 6480464 | Putrescine metabolite inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; more ... | CTD | PMID:22366099 |
| pyrimethamine | increases expression | ISO | RGD:10996 | 6480464 | Pyrimethamine results in increased expression of NOS2 mRNA | CTD | PMID:20193682 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11020457 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NOS2 protein] | CTD | PMID:22919443 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10086329 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11518563 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11500931 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:20417174 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11518563 more ... |
| quercetin | decreases expression | ISO | RGD:730951 | 6480464 | Quercetin results in decreased expression of NOS2 protein | CTD | PMID:17184768 PMID:12144868 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15831208 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16171798 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:20417174 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11500931 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16171798 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11518563 PMID:11500931 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17177504 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15831208 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15831208 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:22210036 more ... |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein] | CTD | PMID:14700523 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:15930438 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18090225 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein] | CTD | PMID:12741479 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Cadmium results in increased expression of NOS2 protein] | CTD | PMID:16226777 |
| quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of NOS2 protein | CTD | PMID:15476665 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [17-(allylamino)-17-demethoxygeldanamycin results in decreased expression of NOS2 mRNA]; more ... | CTD | PMID:11835313 |
| quercetin | decreases expression | ISO | RGD:10996 | 6480464 | Quercetin results in decreased expression of NOS2 mRNA | CTD | PMID:17135264 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Zymosan results in increased expression of NOS2 mRNA] | CTD | PMID:17651994 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11500931 PMID:11518563 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:14563492 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of NOS2 mRNA] | CTD | PMID:19352036 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16171798 more ... |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16171798 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Hemin promotes the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:14563492 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | [3,5-dimethoxy-4'-hydroxystilbene co-treated with Quercetin] results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:17135264 |
| quercetin | decreases expression | ISO | RGD:730951 | 6480464 | Quercetin results in decreased expression of NOS2 protein | CTD | PMID:12144868 PMID:17184768 |
| quercetin | decreases expression | ISO | RGD:730951 | 6480464 | Quercetin results in decreased expression of NOS2 mRNA | CTD | PMID:17184768 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:9581680 |
| quercetin | multiple interactions | ISO | RGD:10996 | 6480464 | Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA] | CTD | PMID:22698256 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA] | CTD | PMID:21295105 |
| radicicol | multiple interactions | EXP | | 6480464 | monorden inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15583003 |
| raloxifene | multiple interactions | EXP | | 6480464 | Carrageenan inhibits the reaction [Raloxifene results in increased expression of NOS2 protein] | CTD | PMID:15860553 |
| raloxifene | decreases expression | ISO | RGD:730951 | 6480464 | Raloxifene results in decreased expression of NOS2 protein | CTD | PMID:20888885 |
| raloxifene | multiple interactions | ISO | RGD:730951 | 6480464 | HMOX1 protein promotes the reaction [[Raloxifene results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:20888885 |
| ranitidine | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein] | CTD | PMID:16169175 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11020457 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of NOS2 mRNA] | CTD | PMID:19796704 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18424637 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased abundance of Nitric Oxide] | CTD | PMID:20712904 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10188978 more ... |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:10188978 more ... |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; more ... | CTD | PMID:20527891 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein] | CTD | PMID:20132809 PMID:20155626 |
| resveratrol | decreases expression | ISO | RGD:10996 | 6480464 | resveratrol results in decreased expression of NOS2 protein | CTD | PMID:10370867 more ... |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:22363816 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15589480 more ... |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15589480 more ... |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein] | CTD | PMID:18551458 |
| resveratrol | decreases expression | ISO | RGD:730951 | 6480464 | resveratrol results in decreased expression of NOS2 mRNA | CTD | PMID:20706672 PMID:22251620 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 protein | CTD | PMID:14990356 PMID:17600658 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16183991 PMID:22952890 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Azoxymethane results in increased expression of NOS2 protein]; more ... | CTD | PMID:21355597 |
| resveratrol | multiple interactions | ISO | RGD:730951 | 6480464 | resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli 0111 B4] results in increased expression of NOS2 protein] | CTD | PMID:19549798 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18513711 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 mRNA | CTD | PMID:14982945 more ... |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 | CTD | PMID:20828608 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Taurocholic Acid results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:16389574 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | wortmannin inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; more ... | CTD | PMID:22952890 |
| resveratrol | decreases expression | ISO | RGD:10996 | 6480464 | resveratrol results in decreased expression of NOS2 protein | CTD | PMID:10370867 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:10086329 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:15589480 PMID:22118570 |
| resveratrol | decreases expression | ISO | RGD:10996 | 6480464 | resveratrol results in decreased expression of NOS2 | CTD | PMID:21945106 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of NOS2 protein] | CTD | PMID:22069489 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 mRNA | CTD | PMID:17416599 PMID:17600658 |
| resveratrol | increases expression | ISO | RGD:730951 | 6480464 | resveratrol results in increased expression of NOS2 protein | CTD | PMID:19846903 |
| resveratrol | multiple interactions | ISO | RGD:730951 | 6480464 | Capsaicin promotes the reaction [resveratrol results in increased expression of NOS2 protein]; more ... | CTD | PMID:19846903 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:21284090 |
| resveratrol | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [resveratrol results in increased activity of NOS2 protein] | CTD | PMID:17666920 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:22118570 PMID:15589480 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:16183991 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of NOS2 protein] | CTD | PMID:16116226 |
| resveratrol | multiple interactions | ISO | RGD:730951 | 6480464 | [resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:22251620 |
| resveratrol | decreases expression | ISO | RGD:730951 | 6480464 | resveratrol results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:22251620 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of NOS2 protein | CTD | PMID:17666920 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 protein | CTD | PMID:17600658 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS2 mRNA | CTD | PMID:17600658 PMID:17416599 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA] | CTD | PMID:16178859 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:16366677 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] | CTD | PMID:20501860 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased expression of and results in increased activity of NOS2 protein] | CTD | PMID:16685418 |
| resveratrol | affects activity | EXP | | 6480464 | resveratrol affects the activity of NOS2 protein | CTD | PMID:17923197 |
| resveratrol | decreases expression | ISO | RGD:10996 | 6480464 | resveratrol analog results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:19066340 |
| resveratrol | multiple interactions | ISO | RGD:730951 | 6480464 | [resveratrol results in decreased expression of NOS2 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:12060119 PMID:22251620 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21914476 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:18513711 PMID:9581680 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA] | CTD | PMID:18812229 |
| resveratrol | multiple interactions | ISO | RGD:10996 | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA] | CTD | PMID:22698256 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lysophosphatidylcholines results in increased expression of NOS2 mRNA] | CTD | PMID:20564508 |
| resveratrol | increases expression | ISO | RGD:10996 | 6480464 | resveratrol results in increased expression of NOS2 mRNA | CTD | PMID:12003803 PMID:22610192 |
| resveratrol | decreases expression | ISO | RGD:10996 | 6480464 | resveratrol results in decreased expression of NOS2 mRNA | CTD | PMID:21189227 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:17651055 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:17651055 PMID:18513711 |
| resveratrol | decreases expression | ISO | RGD:730951 | 6480464 | resveratrol results in decreased expression of NOS2 protein | CTD | PMID:12060119 PMID:22251620 |
| resveratrol | increases response to substance | ISO | RGD:10996 | 6480464 | NOS2 protein results in increased susceptibility to resveratrol | CTD | PMID:12003803 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dimethylnitrosamine results in increased expression of NOS2 mRNA] | CTD | PMID:20422370 |
| rifampicin | multiple interactions | ISO | RGD:10996 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of NOS2 mRNA | CTD | PMID:21224054 |
| rolipram | multiple interactions | EXP | | 6480464 | Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:18710439 |
| rosiglitazone | multiple interactions | ISO | RGD:10996 | 6480464 | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] | CTD | PMID:11343698 |
| rosiglitazone | multiple interactions | ISO | RGD:10996 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] | CTD | PMID:15684285 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:17394460 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:17950491 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:16215386 |
| rosiglitazone | multiple interactions | ISO | RGD:10996 | 6480464 | rosiglitazone inhibits the reaction [[lipopolysaccharide, E. coli 026-B6 co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | CTD | PMID:12566086 |
| rosiglitazone | multiple interactions | ISO | RGD:730951 | 6480464 | rosiglitazone inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] | CTD | PMID:18155663 |
| rosuvastatin | increases expression | EXP | | 6480464 | rosuvastatin results in increased expression of NOS2 mRNA | CTD | PMID:21443142 |
| rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11530235 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 mRNA | CTD | PMID:15135310 more ... |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 mRNA | CTD | PMID:15927086 more ... |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 mRNA | CTD | PMID:15927086 more ... |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 mRNA | CTD | PMID:15795934 more ... |
| rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [IL1B protein results in increased expression of NOS2 protein] | CTD | PMID:8662662 |
| rotenone | multiple interactions | EXP | | 6480464 | Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Rotenone]; more ... | CTD | PMID:7532384 |
| rotenone | multiple interactions | EXP | | 6480464 | Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]; more ... | CTD | PMID:15795934 PMID:15927086 |
| rotenone | multiple interactions | EXP | | 6480464 | 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]]; more ... | CTD | PMID:15927086 PMID:15795934 |
| rotenone | multiple interactions | ISO | RGD:10996 | 6480464 | 5-hydroxydecanoic acid inhibits the reaction [N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]]; more ... | CTD | PMID:16257489 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 protein | CTD | PMID:15795934 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NOS2 mRNA | CTD | PMID:15135310 more ... |
| rotenone | increases activity | EXP | | 6480464 | Rotenone results in increased activity of NOS2 protein | CTD | PMID:15927086 |
| rutin | multiple interactions | ISO | RGD:10996 | 6480464 | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:11500931 PMID:12512693 |
| rutin | multiple interactions | ISO | RGD:10996 | 6480464 | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] | CTD | PMID:12512693 PMID:11500931 |
| rutin | multiple interactions | ISO | RGD:10996 | 6480464 | Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:11500931 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10996 | 6480464 | Buthionine Sulfoximine promotes the reaction [Trioxsalen analog results in decreased expression of NOS2 mRNA] | CTD | PMID:16259964 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine promotes the reaction [Potassium Cyanide results in increased expression of NOS2 protein] | CTD | PMID:16933320 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:7532384 |
| S-nitrosoglutathione | multiple interactions | ISO | RGD:730951 | 6480464 | [NOS2 protein results in increased chemical synthesis of S-Nitrosoglutathione] which results in decreased susceptibility to Carmustine | CTD | PMID:15110396 |
| scutellarin | decreases expression | EXP | | 6480464 | scutellarin results in decreased expression of NOS2 protein | CTD | PMID:16297343 |
| Se-methyl-L-selenocysteine | multiple interactions | ISO | RGD:10996 | 6480464 | selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21213327 |
| Se-methylselenocysteine | multiple interactions | ISO | RGD:10996 | 6480464 | selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:21213327 |
| selenium atom | multiple interactions | ISO | RGD:10996 | 6480464 | Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:17630198 |
| selenium atom | multiple interactions | ISO | RGD:10996 | 6480464 | Selenium inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; more ... | CTD | PMID:14734799 |
| selenomethionine | multiple interactions | ISO | RGD:730951 | 6480464 | Selenomethionine inhibits the reaction [Spermine results in increased activity of NOS2 protein] | CTD | PMID:20121705 |
| sildenafil | decreases expression | ISO | RGD:10996 | 6480464 | sildenafil results in decreased expression of NOS2 protein | CTD | PMID:17101732 |
| sildenafil | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with sildenafil] results in increased expression of NOS2 mRNA; more ... | CTD | PMID:19152827 |
| silibinin | multiple interactions | EXP | | 6480464 | silybin inhibits the reaction [sodium arsenite results in increased expression of NOS2] | CTD | PMID:23070905 |
| silibinin | decreases expression | ISO | RGD:10996 | 6480464 | silybin results in decreased expression of NOS2 protein | CTD | PMID:16788158 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | Niacin inhibits the reaction [Silicon Dioxide results in increased expression of and results in increased activity of NOS2 protein] | CTD | PMID:15182488 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Cadmium Chloride] results in increased expression of NOS2 protein | CTD | PMID:22898625 |
| silicon dioxide | increases expression | ISO | RGD:10996 | 6480464 | Silicon Dioxide results in increased expression of NOS2 mRNA | CTD | PMID:19022359 |
| silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NOS2 mRNA | CTD | PMID:21602193 |
| simazine | decreases expression | ISO | RGD:10996 | 6480464 | Simazine results in decreased expression of NOS2 mRNA; more ... | CTD | PMID:22984576 |
| simvastatin | multiple interactions | ISO | RGD:730951 | 6480464 | Simvastatin promotes the reaction [Doxorubicin results in increased expression of NOS2 protein] | CTD | PMID:18463201 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of NOS2 protein | CTD | PMID:11470468 more ... |
| simvastatin | decreases expression |